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The teleost Nothobranchius furzeri is an annual fish and is the shortest-lived vertebrate that can 
be cultured in captivity. The longer-lived strains of N. furzeri show a median lifespan of 40 weeks 
making it a unique model organism for ageing research. N. furzeri recapitulates the major features 
of mammalian brain ageing, such as gliosis, lipofuscin and iron accumulation and also more global 
changes at transcriptomic- and proteomic-level.  
Neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and 
Fronto-Temporal Dementia (FTD), are the prevalent causes of dementia and are currently viewed 
as cerebral proteopathies, having age as the major risk factor and in which the accumulation of 
specific misfolded proteins is the most relevant causative factor.  
In the initial part of my thesis, I detected age-dependent protein aggregation, and in particular 
ribosome aggregation, in the brain of N. furzeri during physiological ageing. This observation is key 
to suggest this organism as a model for observing and studying neurodegeneration. In my thesis 
work, I laid the groundwork for future studies in this direction, and, in particular, I focused my 
attention on studying PD- related and TDP43-related protein aggregation and neurodegeneration. 
Parkinson’s disease is the second most common age-related neurodegenerative disorder after 
Alzheimer’s disease with an estimated 7-10 million persons affected worldwide. Its main 
neuropathological feature is the aggregation of the phosphorylated form of the protein α-
Synuclein (α-Syn) creating characteristic formations called Lewy bodies in the soma and Lewy 
neurites in neuronal processes. This aggregation is considered the major cause of the 
neurodegeneration of Tyrosine Hydroxylase (TH) enzyme containing central neurons belonging to 
the Noradrenergic and Dopaminergic system in the Substantia Nigra and in the Locus coeruleus 
nuclei, respectively.  
To assess possible PD-related neurodegeneration in N. furzeri, I first analyzed the expression of TH 
in Nothobranchius furzeri brain and realized a whole mount 3D map of the monoaminergic system 
in clarified brains. Secondly, I compared the amount of TH positive cells between young- and old-
animals in the Locus coeruleus and in the hypothalamic posterior tuberculum (the teleost homolog 
to the mammalian Substantia Nigra) to investigate markers of neurodegeneration. I analyzed 
animals at 5, 12 and 37 weeks of age and found a statistically significant age-dependent reduction 
of TH+ neurons in the Locus coeruleus but not in the posterior tuberculum.  
Immunoreactivity for phospho-Synuclein (pSyn) in the soma of Locus coeruleus neurons was 
detected already at 5 weeks of age, indicating initial aggregation early in life, with the signal 
increasing in older samples. No signs of immunoreactivity for phospho-Synuclein were detected in 
the somata of TH+ hypothalamic neurons at any age. This observation supports the link between 
the accumulation of somatic phospho-Synuclein and neurodegeneration that is restricted to Locus 
coeruleus neurons. This observation is also in line with Braak’s staging of human PD development 
according to α-Syn immunoreactivity: Braak hypothesizes a caudo-rostral spreading of aggregation 
and neurodegeneration starting in the vagal nuclei, then spreading to the Locus coeruleus and only 
in later stages involving the Substantia nigra. 
Staining for aggregated proteins in Locus coeruleus cells also revealed presence of aggresomes 
localized mainly in vacuolized areas of cytoplasm devoid of TH staining in old samples. 
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Overall, this data point to N. furzeri showing a pre-symptomatic like form of PD-related 
neurodegeneration during normal ageing. 
FTD is a neurodegenerative disease involving aggregation and mislocalization of TDP-43. TDP-43 is 
normally localized into neuronal nuclei, but in FTD patients it localizes in the cytoplasm near the 
nuclear envelope forming aggregates. 
To assess TDP-43 localization in N. furzeri brain during ageing, I performed immunofluorescence 
labelling on both sections and whole mount brains for TDP-43 in young and old animals and I 
detected abnormal TDP-43 localization in old brains: the protein concentrated in proximity of the 
nuclear envelope. I was also able to detect protein aggregates stained by aggresome dye 
associated with cells showing an abnormal TDP-43 staining, supporting the idea of the correlation 
between abnormal TDP-43 localization and protein aggregation. Moreover, I was also able to 
observe localization of TDP-43 staining overlapping with G3BP in stress granules (SG) in 
accordance with the known role of TDP-43 in regulating SG formation. 
Finally, I also developed organotypic slice culture of Nothobranchius furzeri to exploit the fast 
ageing of this model for in vitro studies. I report culturing of thick brain slices for at least five 
weeks. I could also demonstrate persistence of adult neurogenesis and survival of TH+ cells in 
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1.1 Impact of dementia and neurodegenerative diseases at socio-economical level 
 
Neurodegenerative diseases are the prevalent cause of dementia and are currently regarded as 
cerebral proteopathies, in which the accumulation of particular, disease-specific, misfolded 
proteins is a key pathological mechanism (e.g., Cox et al., 2020; Vaquer-Alicea & Diamond, 2019) 
Dementia is defined by the World Health Organization (WHO) as a syndrome characterized by 
deterioration in cognitive function beyond what might be expected from normal ageing, and it is 
usually of a chronic or progressive nature. Dementia is one of the major causes of disability and 
dependency among older people worldwide: even if ageing is the major risk factor for developing 
dementia, this it is not a normal consequence of ageing itself, but instead it derives from a variety 
of traumas and pathologies affecting the brain. The primary causes of dementia are 
neurodegenerative diseases, Alzheimer’s disease being the most common accounting for about 
60-70% of cases, followed by dementias of vascular origin which are thought to account for 15-
20% of cases in North America and Europe (Wolters & Arfan Ikram, 2019). Other frequent 
neurodegenerative diseases include Lewy bodies pathologies (e.g., Parkinson’s disease) and 
Fronto-Temporal Dementias (FTDs) (WHO, 2019). 
In 2019, approximately 50 million people are affected by dementia and this number is projected to 
increase greatly in the next few years reaching 82 million in 2030 (WHO, 2019). 
At present, no effective treatments have been found for these diseases. Due to the slow and 
progressive nature of these pathologies, combined with the worldwide human median lifespan 
increase, it is evident how dementias pose a significant challenge to society (i.e., the families and 
caregivers of the patients) and to the health system, both economically and in terms of quality of 
life. In fact, in 2015, the total global societal cost of dementia was estimated to be 818 billion 
dollars, equivalent to 1.1% of the global gross domestic product (WHO, 2019), and this cost is 
certain to increase significantly. Thus, finding a cure for neurodegenerative diseases is an 
important goal for biomedical research, leading in recent years to a greatly increased effort in 
terms of public funding invested and studies performed in this field (Cummings et al., 2021; Pickett 
& Brayne, 2019). Conversely, the lack of results in terms of successful treatments discovered in the 
last decades lead the pharmaceutical companies to reduce their effort in terms of research 











1.2 Protein aggregation  
 
Protein aggregation is a process by which proteins lose their functional native conformation and 
undergo insoluble aggregate formation and deposition via initial self-assembly (Merlini et al., 
2001). The process of aggregation is composed of various stages, the first of which is the 
spontaneous dimerization of partially unfolded proteins. These dimers then form more complex 
structures (oligomers) by beta structures annealing, leading in the end at the formation of tight 
polymer stack referred as ‘amyloid fibrils’ (Merlini et al., 2001; Patel & Kuyucak, 2017). This 
fibrillary formations are resistant to denaturation by chemical agents, proteases and heat, and 
cells are not able to remove them, thus they become toxic if their amount surpass a certain 
threshold and they ultimately lead to cell death (Dovidchenko et al., 2014). Protein aggregation 
can lead to effects other than the simple formation of insoluble particles: once aggregation has 
initiated the misfolded protein can interact with heterologous proteins, leading to the 
sequestration of other important cell components (e.g. ribosomal proteins, Kelmer Sacramento et 
al., 2020; S. Banerjee et al., 2020; Gruber et al., 2018) and to an overall remodeling of the cellular 
proteome (Hosp et al., 2017), providing an additional source of toxicity besides the simple 
aggregation. 
The initiation of the formation of the amyloid state can be due to exposition of amide and 
carbonyl groups of the polypeptide backbone chain, allowing for H bonds formation with other 
polypeptide chains. Exposition of these groups can be caused by denaturation of normally folded 
protein, protein overexpression such as to reach the saturation point, peptide cleavage (e.g. Aβ) or 
production of native disordered protein. This process can be initiated also by post-translational 
modifications such as phosphorylation (Eisenberg & Jucker, 2012; Yang et al., 2016).  
Study on the Prion protein revealed that the acquisition of the amyloid conformation leads to the 
toxicity of the misfolded protein. In particular, that the presence of a specific region of the PrP 
protein called Prion-Like Region (PLR) is sufficient for proteins to acquire the same characteristics 
of a self-perpetuation typical of prions (Falsone & Falsone, 2015; Prusiner et al., 1983). This is due 
to the ability of the PRL to fold spontaneously into amyloid-like conformations. The PRL domain 
can be found in various proteins, usually in a modular architecture (Kato et al., 2012).  
Amyloid folding and prion-like behavior is tightly linked to toxicity (Aguzzi & Rajendran, 2009), but 
can also modulate protein function in physiological condition through reversible assembly of 
protein particles and various organisms, ranging from prokaryotes to higher level mammals have 
evolved controlled protein aggregation.  Several proteins have been discovered in neurons that 
gain a new, unique and physiologically relevant function through aggregation (e.g. ARC for 
synaptic inverse tagging or FUS for RNA binging functions) (Bailey et al., 2004; Chernova et al., 
2014; Falsone & Falsone, 2015; Gilks et al., 2004; Nikolaienko et al., 2018; Shelkovnikova et al., 
2013). 
It has been speculated that toxicity of protein aggregation can be avoided if it is reversible as well 
as spatially and temporally controlled. It seems that this control can be achieved by a strict 
regulation of transcript abundance for aggregation-prone proteins and by effective surveillance for 
protein quality control and clearance, thanks to molecular chaperones and different degradation 
machineries (Gsponer & Babu, 2012; Hipp et al., 2014). 
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A striking example of prion-like proteins involved directly in important biological functions are 
proteins involved in Stress Granules (SG) formation. SGs are membrane-less organelles that form 
transiently in the cytosol by liquid phase separation upon different forms of cellular insults, 
contributing to the arrest of mRNA translation (Anderson & Kedersha, 2008; Balagopal & Parker, 
2009). When homeostasis is restored, these granules dissolve rapidly and completely (Falsone & 
Falsone, 2015; Kedersha et al., 2013). In physiological conditions, these assemblies are reversibly 
decomposable into monomers. Their conformational rearrangement occurs, however, in a fashion 
typical of prions: the prion conformer displays structural and physical features of amyloids (self-
organization, cross beta structure), catalyzes its own template-driven conversion and can be non-
genetically transmitted, maintaining at the same time reversibility and a minimal toxic hazard 
(Falsone & Falsone, 2015; Kedersha et al., 2000, 2013; Malinovska et al., 2013). 
This observation is incredibly relevant in a pathophysiological context since alterations in SG 
































1.3 Neurodegeneration and aggregation 
 
Notably, all neurodegenerative diseases are characterized by protein aggregation and consequent 
neuronal death and every neurodegenerative disease is characterized by massive aggregation of a 
specific protein (or combination of proteins) and preferential death of a specific subtype of 
neurons (Merlini et al., 2001; Ross & Poirier, 2004; Saxena & Caroni, 2011; Vaquer-Alicea & 
Diamond, 2019). Aggregation is thought to be one of the main pathophysiological mechanisms 
leading to neurodegeneration, due to the consequent proteostasis collapse and to dysregulation 
of metabolic, signaling and repair pathways, all of which are implicated in cellular maintenance, 
ageing and lifespan control (Cox et al., 2020; Francisco et al., 2020; Kelmer Sacramento et al., 
2020). 
It was discovered that amyloidogenic proteins such as α-Synunclein (α-Syn), Tau, Amyloid-beta (Aβ) 
and TDP-43, the proteins whose aggregation is observed in the most common neurodegenerative 
diseases (AD, PD and FTD), do not have particularly stable three dimensional structures in 
physiological conditions. They tend to assume a more stable form only upon binding to other 
proteins that are their specific interactors (Aguzzi & Calella, 2009; Frost & Diamond, 2010; Perutz et 
al., 2002; Vaquer-Alicea & Diamond, 2019). The misfolded form of these proteins, on the other hand, 
has exposed beta sheet stretches that are prone to bind other proteins with low specificity. 
Therefore, their amyloid folding can act as cross nucleation seed that initiate secondary misfolding 
of a host of other proteins. Disease-associated proteins can also cross-seed their aggregation. It has 
been shown, for example, that α-Syn can initiate Tau deposition in mice (J. L. Guo et al., 2013) and 
that TDP-43, the main protein found in ALS aggregates and involved in FTDs, can act as seed for Aβ 
fibril growth (Fang et al., 2014). In addition, unbiased proteomic analysis of protein aggregates has 
revealed a complex, heterogeneous composition suggesting that sequestration of important 
proteins may result in loss of function (Cox et al., 2020; Furukawa et al., 2011; Hipp et al., 2014; 
Hosp et al., 2017; Radwan et al., 2017; Yang et al., 2016).  
In cases of amyloid folding, these particles can propagate between cells like prion-like particles, 
spreading through axonal projections and leading to specific patterns of dissemination through 
interconnected systems (Desplats et al., 2009; Frost & Diamond, 2010; Nonaka & Hasegawa, 2018; 
Vaquer-Alicea & Diamond, 2019; Volpicelli-Daley et al., 2011). 
Furthermore, indications suggest that Synuclein-based deposits accumulate according to a 
complex pattern, involving intestinal, olfactory, and medullar circuits, before targeting midbrain 
nigral neurons, and this could in principle involve an axonal spreading mechanism, in the same 
manner that injection of α-Syn seeds in healthy mouse brains triggers polymerization of 
endogenous α-Syn and its self-propagation, along with PD symptoms (Hawkes et al., 2007; Luk et 
al., 2012) 
These observations led to the proposition of Braak’s hypothesis of staged evolution of both 
Parkinson’s and Alzheimer’s diseases (for more detail about Braak’s hypothesis see paragraph 1.5) 
Each neurodegenerative disease is characterized by a principal protein aggregate and results in a 
typical progression of neurodegeneration across specific neuronal subpopulation. As disease-
causing proteins tend to be broadly distributed, it appears that certain types of neurons are more 
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vulnerable due to variations in the gene expression and physiological properties (review by Freer 
et al., 2016; Fu et al., 2018; Kundra et al., 2020). 
An interesting theory trying to explain this phenomenon has been proposed by Saxena and Caironi 
(2011), who called this theory the Stressor Threshold Model. A central principle of this hypothesis 
is that misfolding-prone proteins may accumulate upon cell stress in or near the vulnerable 
neurons, to then interfere with neuronal function selectively and cause more neuronal stress, due 
to vulnerability of those neurons. This occurrence of events would thus favor proteostasis 





































1.4 Ageing as major risk factor for neurodegenerative diseases  
 
Neurodegenerative diseases are caused by a combination of protein aggregation and failure of 
cellular stress response pathways. It is well known that the ability of cells to maintain the integrity 
of their homeostasis pathways diminishes with advancing age, and this likely explains that 
prominent role of age as a risk factor for neurodegenerative diseases (Hou et al., 2019; Kaushik & 
Cuervo, 2015; Mattson & Magnus, 2006; Tran & Reddy, 2021)  
To conceptualize the multifaceted aspects of aging, Lopéz-Otín et al. (López-Otín et al., 2013) have 
proposed nine hallmarks of ageing (i.e., genomic instability, telomere attrition, epigenetic 
alterations, mitochondrial dysfunction, deregulated nutrient sensing, loss of proteostasis, cellular 
senescence, stem cell exhaustion and altered intercellular communication). All these hallmarks 
were observed in neurodegenerative diseases (as reviewed in Hou et al., 2019) . 
Mitochondrial dysfunction seems to have a particularly prominent role. Aggregation of α-
Synuclein and mitochondrial dysfunction seems to have a synergistic relation (Poewe et al., 2017; 
Rocha et al., 2018). 
It is also important to note that the genes identified as causative of  familial forms of PD (i.e., 
Pink1, DJ-1, LRRK2, Parkin) are also linked to mitochondrial function and stability (R. Banerjee et 
al., 2009; Bogaerts et al., 2008)., It remains to be determined whether these mutations cause 
Parkinson’s disease directly via the impairment of mitochondrial function or through other 
pleiotropic mechanisms. α-Syn is physiologically involved in the vesicle releasing mechanism at 
synapses and its dysfunction may cause deficits through possible alteration of SNARE complex 
formation; the mechanistic relationship between α-Synuclein mutations and PD may thus involve 
also synaptic transmission and excitability (Bridi & Hirth, 2018).  
Likewise, DJ-1 has a role as oxidative stress sensor, and Parkin also has a role in stress protection, 
suggesting that the relationship between these genes and PD may also involve cellular stress 
pathways in addition to mitochondrial stress (R. Banerjee et al., 2009). 
Similarly, it has been observed that an age-related decline in the protein PGC1α, which is involved 
in the promotion of cellular plasticity, mitochondrial biogenesis and energy production, has a 
causal relationship to the increase of aggregated proteins, augmented ER stress and faster 
progression of disease in animal models of neurodegenerative diseases and it has also been 
directly linked to α-Synuclein aggregation (Cui et al., 2006; Eschbach et al., 2015). 
Ageing is also strictly associated with progressive loss of proteostasis and its relation with protein 
aggregation has been extensively studied (Alavez et al., 2011; Balch et al., 2008; Kaushik & Cuervo, 
2015; Ray, 2017). Wide proteome remodeling has also been observed in the ageing model 
organisms C. elegans and Nothobranchius furzeri, together with an increase of aggregation 
(Kelmer Sacramento et al., 2020; Walther et al., 2015). Among the many pathways affected by 
ageing, two systems can be identified as key factors in proteostasis dysfunction: proteasome and 
ribosome. 
The proteasome machinery (UPS, Ubiquitin-Proteasome System) plays an important role in 
preventing misfolded protein aggregation, especially in neurons (Falsone & Falsone, 2015) and its 
pharmacological inhibition can lead to aggregation and neurodegeneration in different model 
organisms (Matsui et al., 2010; Romero-Granados et al., 2011). Also genetic impairments of UPS 
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system can lead to neurodegeneration and inclusion formation reminding of Lewy bodies (Bedford 
et al., 2008). Deletion of a single proteasomal subunit is, strikingly, sufficient to drive 
mislocalization and precipitation of TDP-43 and FUS in motor neurons evoking ALS (Amyotrophic 
Lateral Sclerosis) symptoms in mice (Tashiro et al., 2012). Lastly, it has been demonstrated that 
proteasome inhibition leads to protein synthesis inhibition (Ding et al., 2006). 
Ribosomes constitute the major protein component in the cytoplasm (Beck et al., 2011) and they 
obviously have a major role in the control and maintenance of proteostasis via their role pf protein 
translation. Thus, their dysregulation and aggregation have a significant impact on the loss of 
proteostasis. It has indeed been shown how ribosomes can be found in aggregates of proteins 
involved in neurodegenerative diseases (S. Banerjee et al., 2020; Gruber et al., 2018), creating a 
link between neurodegenerative diseases, proteostasis imbalance and ribosome sequestration. 
Both proteasome and ribosome show loss of stoichiometry and down-regulation during aging of N. 
furzeri (Kelmer et al., 2020) 
Given the wealth of experimental data and the evident correlation of ageing and 
neurodegenerative diseases in humans, it is safe to assume that there are links between ageing-
related signaling pathways, ER stress, mitochondrial dysfunction and protein misfolding, leading all 
together to greater neuronal vulnerability and neurodegeneration risk. 
The Stressor Threshold Model states that the disease can remain for extended periods at an 
overall sub-threshold level to escalate into full blown pathology only later in life (Saxena & Caroni, 
2011). 
Thus, the initiation of neurodegenerative diseases could be initiated at any ages by chronic 
alteration of cellular homeostasis pathways, and then the convergence of other stressors can lead 
to dysfunction and degeneration of more vulnerable neurons. Supra-threshold dysfunction and 
progressive neurodegeneration would become evident only when age-related stressor tolerance 
decreases. 
This hypothesis is concordant with the observation that accumulation of misfolded proteins is 
often not sufficient to cause disease. Studies conducted in human populations suggest how 
additional factors must combine with the age-related accumulation of misfolded proteins for 
disease to develop. Indeed, the presence of characteristic macroscopic protein aggregates in the 
same neurons can be observed in brains of some aged but functionally preserved subjects and do 
not represent sufficient evidence to assume the presence of the pathology, if other signs of major 













1.5 Parkinson’s disease principal features 
 
Parkinson’s disease is the second most common age-related neurodegenerative disorder after 
Alzheimer’s disease. An estimated 7-10 million people worldwide suffer from Parkinson’s disease.  
Clinically, this pathology is characterized by motor and non-motor symptoms. The four main motor 
symptoms are tremor at rest, rigidity, bradykinesia and postural instability. In addition, flexed 
posture and freezing is observed in most patients. Some of the non-motor symptoms are, among 
the others, cognitive impairment, depression, sleep disorders and fatigue (Jankovic, 2008; Poewe 
et al., 2017). 
The main histopathological hallmarks are the formation of Lewy neurites within axons and 
dendrites, Lewy’s bodies in cells’ soma, and neurodegeneration of Tyrosine Hydroxylase 
expressing neurons, especially in the Substantia Nigra pars compacta (SNpc), and in the Locus 
coeruleus (Del Tredici & Braak, 2012; Schneider & Obeso, 2014; Zarow et al., 2003).  
Lewy’s bodies and neurites are composed primarily of α-Synuclein aggregates carrying a specific 
phosphorylation at the aminoacid residue Serine 129. Up to 90% of the aggregated form of α-
Synuclein carries this specific post-translational modification (Samuel et al., 2016). 
Having observed the elevated presence of this protein into the aggregates, Braak and colleagues 
linked the spatial progression of the pathology to the diffusion of α-Syn stained aggregates. They 
formulated the hypothesis that the aggregates spread in a prion-like manner and follow an 
ordered path, starting from the vagal nerve, progressing to the Locus coeruleus, then to the 
Substantia Nigra, and eventually reaching limbic and neocortical brain regions. Based on such 




Fig 1: Principal characteristics of Parkinson’s disease. Aggregation of the protein α-Synuclein leads to the formation of Lewy bodies 
and Lewy neurites. Initial preclinical stages of Parkinson’s disease are identified by the presence of Lewy’s bodies and neurites in 
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the dorsal nucleus of the vagal nerve and into the Locus Coeruleus. The following stage involves the Substantia Nigra and the 
appearance of the firsts motor symptoms, then the aggregates reach more frontal areas involving the cortex and leading eventually 
to the appearance of the non-motor symptoms. Modified from Poewe et al., 2017. 
 
One of the most affected areas in Parkinson’s disease is the Substantia Nigra pars compacta, 
formed primarily by dopaminergic neurons, whose dysfunctions account for the major clinical 
manifestations of PD (Alexander, 2004). These neurons are particularly vulnerable to 
mitochondrial stress, and various studies have been conducted with the aim of linking ageing, 
mitochondrial dysfunction, and ROS production to Parkinson’s. In particular, it was discovered that 
deficits of the complex I of the respiratory chain have a link to sporadic cases of PD, and animals 
treated systemically with rotenone (a complex I inhibitor) showed an enhanced ROS production in 
the Substantia nigra, dopaminergic neuron loss and Lewy bodies formation(Keeney et al., 2006; 
Sherer et al., 2003; Thomas et al., 2012). This and other observations show a clear association 
between Parkinson’s disease and protein aggregation and a mitochondrial dysfunction, but the 
actual causal relationship is still to be determined.  
Mitochondrial vulnerability might be a first hit target, predisposing Substantia nigra neurons to PD 
possible development or the mitochondrial respiratory chain dysfunctions may be an aggravating 
consequence, rather than a cause of disease (Saxena & Caroni, 2011). 
The etiology of PD may thus require overburdening of stress pathways, also involving 
mitochondria, which are particularly sensitive in dopaminergic neurons of the Substantia nigra.  
Locus coeruleus is another nucleus highly affected by neurodegeneration during Parkinson’s 
disease (Del Tredici & Braak, 2013; McMillan et al., 2011; Zarow et al., 2003). Locus coeruleus is 
located in the pons and is the main source of noradrenaline in the brain (Szabadi, 2013). During 
Parkinson’s disease, Lewy bodies formation in the Locus coeruleus cells is an early event (stage 2 of 
Braak’s stadiation, Braak et al., 2002) that precedes onset of motor symptoms and degeneration 
of the Substantia nigra (Rommelfanger & Weinshenker, 2007; Zarow et al., 2003). 
The Locus coeruleus contains a relatively small amount of neurons that sends diffuse projections 
with neuromodulatory action to the entire brain (Szabadi, 2013) and it is involved in a number of 
functions ranging from arousal and attention to learning, autonomous system regulation and 
others (Bari et al., 2020; Szabadi, 2013). In particular, Locus coeruleus is of extreme importance in 
maximizing task -oriented performance, especially under stress or novel circumstances 
(Benarroch, 2009; Del Tredici & Braak, 2013). 
In Parkinson’s disease, loss of noradrenergic neurons is associated with cognitive decline (Cash et 
al., 1987; Peterson & Li, 2018). As the Locus coeruleus projects heavily to the hippocampus and 
parahippocampal formation (Szabadi, 2013; S. Zhang et al., 2016), loss of noradrenergic signaling 
may lead to hippocampal dysfunction and memory deficits. 
It is thus important to also consider neurodegeneration of this area as critical during Parkinson’s 
disease development, even if the derived symptoms may be less evident than those deriving from 







Fig 2: Main areas affected by neurodegeneration in Parkinson’s disease in post-mortem human brain samples. 
Neurodegeneration in the Substantia nigra (upper panel) and Locus coeruleus (lower panel) Showed as TH 
immunoreactivity. Modified from Poewe et al., 2017 and McMillan 2011. 
 
Notably, presence of phospho-Synuclien (pSyn) immunoreactivity and Lewy bodies are not an 
exclusive feature of PD. They are found in   ̴10% of clinically unimpaired subjects over the age of 60 
with a distribution similar to PD, but showing lesser density of inclusions and a lesser degree of 
Tyrosine Hydroxylase (TH) reduction, as compared to what observed in PD, suggesting that pSyn 
immunoreactivity and LB formation are already detectable at preclinical stages, before the onset 
of motor symptoms (Dickson et al., 2008; Forno, 1969; Fumimura et al., 2007).   
Several approaches were undertaken to model PD in animal models. Dopaminergic loss and the 
associated motor symptoms can be induced in rodents and primates by acute pharmacological 
treatments (for reviews see Johnson & Bobrovskaya, 2015; Meredith & Rademacher, 2011). These 
models are useful to test acute neuroprotection of therapeutical interventions, but fail to model 
the progressive and age-associated nature of PD. An alternative approach envisages the genetic 
manipulation of either α-Syn or other PD-associated genes like LRRK2, PINK1, Parkin, or DJ-1 
(Jagmag et al., 2016). Some of these models show a more progressive onset of the 
neurodegeneration but, in most cases, the disease is modelled in young or, at best, in young adult 
animals. It should also be noted that the majority of PD cases do not have a clear genetic origin 
but are classified as idiopathic. Teleost fishes like Medaka and Zebrafish have also been utilized to 
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model PD with similar approaches (L. J. Flinn et al., 2013; Matsui, 2017; Matsui et al., 2009, 2012; 
Uemura et al., 2015). 
MTPT (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) is a commonly used toxin to mimic PD via 
induction of midbrain dopaminergic neuron loss. Its use in zebrafish leads to the same type of 
neurodegeneration observed in mammals (Lam et al., 2005; McKinley et al., 2005; Sallinen et al., 
2009; Wen et al., 2008) causing motor deficits (Robea et al., 2020; Sarath Babu et al., 2016). 
Effects of MPTP can be prevented by inhibition of monoamine oxidase-B (MAO-B) or the 
dopamine transporter (DAT), indicating a conservation in the mechanisms (McKinley et al., 2005). 
Alternatively, various zebrafish transgenic lines have been created in attempt to induce PD. A 
Pink1 KO line shows reduction of TH neurons but not behavioral deficits (Bandmann et al., 2010), 
while a Parkin KD lead also to a reduction of dopaminergic neurons and mitochondrial disfunction 
but not to an alteration of swimming behavior (L. Flinn et al., 2009). KD or mutation of LRRK2 in 
zebrafish leads to dopaminergic neuron loss, aggregation and swimming deficits (Prabhudesai et 
al., 2016; Sheng et al., 2010) 
These models offer a cost-effective alternative to study PD but suffer from the same limitations of 
the rodent models, failing in reproducing the progressive staging of PD and ignoring the aging 
context in which PD arises, being realized in young adult fish at best. 
For a more precise modelling of the disease, it would be crucial to carry such studies in the context 
of aging animals, which is the natural environment for neurodegenerative diseases, and therefore 
the use of animals such as Nothobranchius furzeri could provide the right platform in which to 
























1.6 TDP-43 and its role in Fronto-Temporal Dementia (FTD) 
 
TAR DNA-binding protein 43 kDa (TDP-43) is an RNA-binding protein involved in RNA metabolism 
(Alami et al., 2014; Buratti & Baralle, 2001; Ishiguro et al., 2016; Kim et al., 2010). It was first 
described in 1995 as a protein associated with HIV transcription (Ou et al., 1995) and reconsidered 
later on as an important component of splicing (Buratti & Baralle, 2001; Polymenidou et al., 2011), 
mRNA transport and translation (Chu et al., 2019; Ishiguro et al., 2016; Neelagandan et al., 2019). 
TDP-43 It is prone to aggregation (B. S. Johnson et al., 2009) due to the presence of an inherently 
disordered domain at the C-terminus of the protein showing prion properties involved in 
functional protein aggregation (Louka et al., 2020; Udan & Baloh, 2011). Recently, TDP-43 has 
been found to be the major component of insoluble intracellular inclusions in motor neurons 
affected by ALS and in 90% of patients suffering from the  α-Synuclein, Tau negative Ubiquitin 
subtype of Fronto-Temporal Dementia (FTD) (Mackenzie & Rademakers, 2008; Neumann et al., 
2006). 
Hallmarks of these diseases are the presence of aberrant, polyubiquitinated and 
hyperphosphorylated cytosolic aggregates of TDP-43 in different areas of the central nervous 
system (Neumann et al., 2006; Prasad et al., 2019). An increasing consensus is building on the 
notion that TDP-43 aggregation is not only a marker, but represents the pathological mechanism 
of these diseases (Hergesheimer et al., 2019). 
Stress granule formation is one of the many cellular protective mechanisms as a response to 
cellular stress (Anderson & Kedersha, 2009). Their formation is initiated by the oligomerization of 
the core proteins Ras GTPase-activating protein-binding protein 1 (G3BP) and Cytotoxic Granule 
Associated RNA Binding Protein (TIA1) whose expression is regulated by TDP-43 (Gilks et al., 2004; 
McDonald et al., 2011; Tourrière et al., 2003). TDP-43 can be found in stress granules under 
cellular stress conditions and TDP-43 positive pathological inclusions in post-mortem tissues from 
ALS patients are positive for stress granule markers (Liu-Yesucevitz et al., 2010; Parker et al., 
2012). 
As already discussed, functional prion-like aggregates and stress granules seem to organize 
themselves and assemble/disassemble, depending on the cellular state, exploiting the aggregation 
properties of the PRL domain of the protein composing the granules themselves. 
It has also been discussed how these organelles must preserve reversibility as a prerequisite for 
physiological function. Processes interfering with the assembly/disassembly, and thereby the 
steady-state integrity of SG, have been associated to misfolding, mislocalisation, or sequestration 
of various SG components, such as TDP-43, FUS, and hnRNPA isoforms, which are all major 
regulators of inclusion body neuropathologies (Dudman & Qi, 2020; Iguchi et al., 2013; 
Shelkovnikova et al., 2013).   
TDP-43 is not a primary nucleator of SGs but influences size, morphology and formation kinetic of 
this organelle. Mutations in TDP-43 reducing its ability to incorporate into SGs or its complete 
deletion leads cells to a delayed formation of SGs that show also irregular shape when present 
(Besnard-Guérin, 2020; Khalfallah et al., 2018; McDonald et al., 2011). 
In the event of a persistent cellular stress, TDP-43 localizes initially to SGs, then detaches and 
forms insoluble cytoplasmic inclusions (Parker et al., 2012). Inclusion formation has been observed 
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upon overexpression of mutated forms of TDP-43 with increased cytosolic/SG localization or 
increased aggregation propensity (Besnard-Guérin, 2020; Cohen et al., 2011; W. Guo et al., 2011). 
Moreover, aggregation-prone TDP-43 mutants induce aggregation of SGs, suggesting that TDP-43 
can favor the transition from physiological to pathological conformation (Cohen et al., 2011). 
Several animal models based on overexpression were developed to model TDP-43-mediated 
diseases (Liu et al., 2013), including zebrafish models (Asakawa et al., 2020; Bose et al., 2019; 





































1.7 The turquoise killifish Nothobranchius furzeri as a possible model for the study of idiopathic 
neurodegenerative diseases 
 
Ageing is a complex process that affects all organs and should be studied in the entire organism. 
The relatively long median lifespan of vertebrates makes the use of these animal models 
expensive, and researchers utilize mostly invertebrate animals or in vitro models to perform the 
majority of ageing studies. This approach, although useful, entails several limitations, including the 
great differences in physiology and body organization between mammals and invertebrates.  
On the other hand, to avoid the cost, in terms of money and time, of waiting for the animals to 
age researchers have developed genetic approaches to overexpress pathologically-mutated 
proteins or to use toxins in order to induce a pathological phenotype in relatively young or young 
adult animals as a models of age-related neurodegenerative diseases. This approach has led to 
useful information regarding the downstream molecular players involved in neurodegenerative 
diseases, but it has proven to be, in the end, not accurate enough to recapitulate the state of 
pathology observed in humans to allow for the development of a successful cure. Moreover, as 
discussed extensively in the previous paragraphs, ageing entails progressive changes in the brain 
both at cellular and molecular level, and those changes are tightly related to neurodegenerative 
diseases and aggregation. Thus discarding completely the study of the pathology in the correct 
ageing context, leads unavoidably to a partial recapitulation of the human condition. 
A model representing an equilibrium between the technical needs of research (low costs, short 
time, and ease of manipulation) and the right characteristics needed to conduct a study that 
recapitulates in the most accurate way possible what is observed in humans is therefore needed. 
The turquoise killifish Nothobranchius furzeri has emerged in the last decade as a valuable new 
model for ageing studies. N. furzeri belongs to the group of the African annual killifishes that are 
all characterized by a lifespan of the duration inferior of one year (Cellerino et al., 2016). This trait 
is a natural consequence of the evolutionary processes that enables survival in their temporary 
habitat. N. furzeri originates from Eastern African savannah and lives in temporary ponds that 
appear during the brief rain season and last only few months (Cellerino et al., 2016). In that short 
period of time, the fish need to go through their entire life cycle of hatching, growing, and 
reproducing. At the end of rain season, the ponds desiccate and all adult fish die. Survival of the 
species is warranted by the ability of the embryos to enter diapause; a state of metabolic 
dormancy that blocks the development in order to survive the hostile desiccation conditions (Dolfi 
et al., 2019). Interestingly, the short lifespan is maintained also in the laboratory in constant 
presence of water (Baumgart, Cicco, et al., 2014; Valdesalici & Cellerino, 2003). In particular, 
N. furzeri has, to date, the record for the shortest median lifespan for a vertebrate that has been 
raised in a laboratory; the shortest living strain of this species being GRZ, which has a lifespan of 
only 14 weeks (Terzibasi et al., 2008), while longer-lived strains can show a maximum lifespan 
(defined as 10% of population survivorship) up to 40 weeks of age (Terzibasi Tozzini et al., 2013). . 
Increasing evidence has shown that N. furzeri shares molecular, histopathological and behavioral 
ageing-related signatures with mammals (Cellerino et al., 2016) 
N. furzeri exhibits all the most common phenotypes linked to  mammalian ageing, such as 
lipofuscin accumulation (Terzibasi Tozzini et al., 2013), skin depigmentation, muscle atrophy and 
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spinal curvature (Fig 3) (Cellerino et al., 2016), along with behavioral deficits including reduced 
spontaneous locomotor and exploratory activity, suggesting a decline in both cognitive and motor 
functions (Genade et al., 2005). 
Examining brain ageing more specifically, N. furzeri shows extensive gliosis, lipofuscin, iron 
accumulation and reduction of neurogenesis (Ripa et al., 2017; Terzibasi Tozzini et al., 2013; 
Tozzini et al., 2012). Moreover, high-throughput expression profiling approaches have detected  
uncoupling of protein and transcript regulation, loss of stoichiometry in several protein complexes, 
reduced proteasome function and ribosome aggregation (Kelmer Sacramento et al., 2020). These 
same mechanisms were previously observed during ageing in C. elegans (David et al., 2010; 
Walther et al., 2015) and are known to be linked to aggregation and neurodegeneration (Falsone 
& Falsone, 2015; Gruber et al., 2018; Matsui et al., 2010; Romero-Granados et al., 2011; Tashiro et 
al., 2012). 
Lastly, the possibility to insert human pathogenic mutations in the N. furzeri ortholog gene using 
CRISPR/Cas9 and homologous recombination expands the possibility of applications for this model 
(Harel et al., 2015). 
The general anatomical organization of the central nervous system is conserved between fish and 
mammals and some specific homologous cell populations (such as cathecolaminergic neurons) 
making teleost fishes valuable models for neurobiological investigations with translational 
potential.  
In 2019, Matsui and colleagues (Matsui et al., 2019) utilized Nothobranchius furzeri to study 
Parkinson-like neurodegeneration and observed an age dependent accumulation of αSyn. They 
report age-dependent neuronal loss in both noradrenergic neurons located into the locus 
coeruleus and in the dopaminergic population forming the hypothalamic posterior tuberculum, the 
putative teleost homolog of the substantia nigra (Kaslin & Panula, 2001; Rink & Wullimann, 2001) 
as identified by Tyrosine Hydroxylase (TH) immunoreactivity. This result was supported also by a 
reduction of TH expression both at protein and RNA level as verified by Western blotting and 
qPCR. Moreover, knock-out of α-Syn using CRISPR/Cas9 was sufficient to abolish degeneration of 
TH positive cells. 
This unique asset of characteristics makes of N. furzeri a model that recapitulates both the 
advantages of vertebrates (similarity with mammals in terms of anatomy and genetic homology) 
and invertebrates (short lifespan, fast ageing, easy transgenesis). Moreover, recent evidence 
pointing to age-related aggregation and neurodegeneration in N. furzeri via mechanisms similar to 
those observed in mammals strengthens further the potential of this organism as a model enable 







Fig 3 : Ageing of the fish Nothobranchius furzeri from (Platzer & Englert, 2016). The same male of MZM-04/03 





































1.8 Organotypic cultures for the study of Parkinson’s disease and TDP-43 
 
In vitro dissociated cell cultures are widely used in any field of biology and medical research. They 
enable the study of a great variety of cell types in an isolated, defined and easily manipulated 
environment, maintaining at the same time the basic morphological and physiological 
characteristics of the cells under study. Moreover, this in vitro technique is in concordance with 
the principle of the three R (Replacement, Refinement, Reduction) by reducing the number of 
animals utilized for experiments and transferring the treatments phase (and associated suffering) 
to the in vitro condition. However, one of the major disadvantages of this technique is the lack of a 
3D structure and cell-to-cell contacts. This disadvantage is particularly pertinent in the case of CNS 
structures whose connections are destroyed upon dissociation. Organotypic culture maintain the 
overall structure of the area of interest as well as the local patterns of synaptic connectivity and 
local interactions with the surrounding cells, representing a much better model of the in vivo 
situation. 
Organotypic cultures of hippocampus from rat pups was first established by  Gähwiler, 1984 and 
then extended to many other CNS structures such as retina (Gancharova et al., 2013), 
hypothalamus, cerebellum and others (Eun et al., 2007; Wolf, 1970). The method consists 
primarily in cultivation of thick brain slices (ranging from 100µm to 500µm) cultured over 
semipermeable membranes (Stoppini et al., 1991) that maintain the tissue at the interface 
between medium and atmosphere in order to allow oxygen and nutrient exchange (Humpel, 2015; 
Stoppini et al., 1991). 
The advantages of culturing tissue slices, typically obtained from very young animals, for 
prolonged periods of time ex vivo are numerous and consist primarily in the maintenance of the 
overall in vivo architecture of the isolated sample, the lack of hematoenchephalic barrier and the 
extreme ease of experimental interventions. 
Organotypic culture have been extensively utilized for the study of both Substantia nigra and 
Locus coeruleus. Culturing of these nuclei has been performed for decades (Jaeger et al., 1989; 
Knöpfel et al., 1989) and the maintenance of their morphological and physiological characteristics 
have been proved (Rohrbacher et al., 2000). Treatment with toxins to induce Parkinson-like 
neurodegeneration has been tested (McCaughey-Chapman & Connor, 2017; Stahl et al., 2009; 
Testa et al., 2005) as well as neurodegeneration via rescission of nigro-strialtal pathway (Daviaud 
et al., 2014).  
Organotypic slices were utilized also to study TDP-43-realted neuropathologies; treatment of 
mouse brain slices with tunicamycin lead to cytoplasmic TDP-43 inclusion (Hicks et al., 2020; 
Leggett et al., 2012) and organotypic cultures from rat expressing a human mutated form of TDP-
43  has been shown to develop astrogliosis and microgliosis and have enabled the study of 
secreted factors which induce selective neuronal death (Bi et al., 2013). 
This technique is well-developed and widely used for mammalian models, but only few  attempts 
have been performed in teleost, mainly using retina (Kustermann et al., 2008; Lahne et al., 2017) 
whole embryo (Langenberg et al., 2003) and one attempt at whole brain culturing for one week 
(Tomizawa et al., 2001). To the best of my knowledge, there are no reports of long-term brain 
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organotypic cultures in teleosts. Long-term organotypic cultures in N. furzeri could provide a 
unique system to study brain aging ex-vivo.  
 
 
1.9  Aim of the study 
 
Considering the advantages that a model organism such as Nothobranchius furzeri offers to the 
field of ageing-related pathology, I assessed if N. furzeri could be utilized as a model to study 
neurodegenerative diseases, focusing on Parkinson’s disease and TDP-43 related pathologies.  
First, I investigated whether accumulation of protein aggregates is a general feature of N. furzeri 
ageing. 
Secondly, I investigated the neurodegeneration of the nuclei majorly affected during Parkinson’s 
disease (i.e., the locus coeruleus and the area homologous to the substantia nigra).  
Thirdly, I specifically investigated the subcellular localization of TDP-43 in young and old animals. 
Lastly, I developed a protocol to realize long-term organotypic cultures of N. furzeri brain slices 
with the prospect of utilizing this technique, in the future, to study brain ageing in vitro and to test 





 2. Materials and Methods 
 
2.1 Fish maintenance and sampling 
 
The MZM-222 strain fish were hatched and housed locally in a Tecniplast system with automatized 
water flow and pH and salinity control. All the animals were hatched, fed and maintained as 
described in detail in (Terzibasi et al., 2008). 
The protocols of fish maintenance were carried out in accordance with all animal use practices 
approved by the Italian Ministry of Health (Number 96/2003a) and the local animal welfare 
committee of the University of Pisa.  
Eggs were maintained on wet peat moss at room temperature in sealed Petri dishes. When 
embryos had developed, eggs were hatched by flushing the peat with tap water at 16–18 °C. 
Embryos were scooped with a cut plastic pipette and transferred to system tank. Fry were fed with 
newly hatched Artemia nauplii for the first 2 weeks and then weaned with finely chopped 
Chironomus larvae. The system water temperature was set at a constant 27 °C. 
At the desired age, fish were sacrificed via anesthetic overdose (Tricaine, MS-222), in accordance 
with the prescription of the European (Directive 2010/63/UE) and Italian law (DL 26/04-03-2014), 
and the brain was immediately extracted under a stereomicroscope and fixed overnight in a 
solution of PFA 4% in PBS. 
Samples used for Sca/eS procedure were then gradually dehydrated by sequential steps of 
incubation in solutions with growing EtOH concentration (25%, 50%, 75%) and finally stored at -
20° in EtOH 90% until use. 
Samples used for immunofluorescence were instead incubated overnight in sucrose 30% at 4°C 
and the day after were included in cryo-embedding medium (Tissue-Tek® O.C.T., Sakura Finetek). 
Serial slices of 25 µm of thickness were then cut using a Leica cryostat and collected on Superfrost 


















2.2 AbSca/e procedure 
 
Sca/eS technique is a clarification technique (Hama et al., 2015) and was an improvement of the 
first Sca/e technique (Hama et al., 2011) which was slower and had the drawbacks of removing the 
lipids and increase the sample size of approximately 1.25 times.  
We followed the principal steps of the AbSca/e technique, which is a subtype of Sca/eS thought 
especially to combine immunofluorescence and tissue cleraing, adapting some of the steps to the 
considerably smaller size of Nothobranchius furzeri brains. All the steps and the solutions used for 
this procedure are summarized in tables 1 and 2. 
Briefly, the samples were re-hydrated via incubation in solutions containing decreasing 
concentrations of ethanol (90%->75%->50%->25%->PBS) and adapted with the S0 solution for 18h 
at 37°C. Then the samples were permeabilized with sequential incubations in A2-B4(0)-A2 
solutions at 37°C. After permeabilization the samples were de-Sca/ed trough incubation in PBS for 
6h at RT followed by incubation with primary antibody in AbSca/e solution for 3 days at 4°C, rinse 
twice in AbSca/e for two hours each and incubation with secondary antibody for 18h at 4°C. The 
samples were then rinsed for 6h in AbSca/e and subsequently in AbRinse solution twice for 2 
hours. After a re-fixation step in PFA4% for 1 h and a rinse in PBS for another hour the samples 
were finally cleared in Sca/e S4 for 18h at 37° and maintained in Sca/eS40 at 4° until imaging. The 




















Table 1. AbSca/e protocol. In this table are listed all the steps of the AbSca/e protocol that I used to clear and stain 
Nothobranchius furzeri brains. The principal difference with the original AbSca/e procedure consists in the steps of 
incubation with the antibodies; the original article suggested to perform both incubations at 37° for two days but, in 
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our case, this led to an high background staining, therefore we decided to perform a longer incubation at a lower 






























Table 2. AbSca/e solutions. In this table are listed the compositions of each solution used to perform AbSca/e. No 




















2.3 Immmunofluorescence and Proteostat™ Aggresome staining 
 
We performed immunofluorescence experiments on cryo-sections of 25 microns and proceeded 
as previously described (Tozzini et al., 2012). Briefly we washed the sections in PBS to remove the 
cryo-embedding medium; then we performed an acid antigen retrieval step (Tri-sodium citrate 
dehydrate 10mM, tween 0,05%, pH6). Afterwards, we stained the section with aggresome 
(ProteoStat™ Aggresome Detection Kit, Enzo Life Sciences Inc.; for more details see Shen et al. 
2011) as follows: we applied a solution 1:2000 of aggresome dye in PBS for 3 minutes, rinsed in 
PBS and left the sections immersed in 1% acetic acid 40 minutes for de-staining. We applied 
blocking solution (5%BSA, 0,3% Triton-X in PBS) for 2 hours, then the primary antibody at proper 
dilution in a solution of 1% BSA, 0,1% triton in PBS, and incubated the samples overnight at 4°C. 
After rinsing in PBS, the following day secondary antibody was applied at a 1:400 dilution in the 
same solution used for the primary antibody. After 2 hours, slides were rinsed 3 times with PBS 
and mounted with a specific mounting medium added with nuclear staining (Fluoroshield DAPI 
mounting, Sigma-Aldrich). List of the antibodies utilized, and their working dilutions can be found 
in table 3. 
Tab. 3 List of antibodies utilized in the immunofluorescence experiments. 
 
2.4 AbSca/e samples images acquisition and processing 
To analyze the AbSca/e treated samples we acquired images on a Leica Ire2 confocal microscope 
using a 20x objective, exciting with an Ar-laser (488 nm).  
We acquired 1024x1024 pixel sequential focal planes along the z axis, at a distance of 1.5 µm each, 
of the regions of interest and then processed the 3D reconstruction utilizing the Bitplane Imaris™ 
software. First, we applied median filtering to reduce background, then we adjusted the tone 
curve accordingly to the characteristics of the imaged sample. 
To count the TH+ cells in the locus coeruleus and the hypothalamus of Nothobranchius furzeri 
brain we utilized the Imaris™ ‘Ortho Slicer’ function to optically isolate portions of the z-stack and 
the function ‘Spots’ to manually count every TH positive cell.  






Antibody Product type Working dilution Company (Cat N.) 
TDP-43 Rabbit Polyclonal 1:1200 Proteintech (10782-2-AP) 
TDP-43 Rabbit Monoclonal 1:500 AbCam (ab190963) 
G3BP Mouse Monoclonal 1:500 AbCam (Ab56574) 
TH Rabbit Monoclonal 1:500 AbCAm (ab75875) 
pS129 Mouse Monoclonal 1:500 BioLegend (825702) 
PCNA Mouse Monoclonal 1:500 Dako (M0879) 
LAMP1 Rabbit Polyclonal 1:500 AbCam (Ab24170) 
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2.5 Immunofluorescence images acquisition and processing 
Images were acquired using a Zeiss Axiovision microscope equipped with Apotome slide and 
subsequently processed using the suite Zen Blue.  
Single area images were acquired using two different magnifications (objectives 40x and 63x both 
oil immersion) as z-stacks formed by multiple focal planes at a distance of 0.5 µm each.  
 
2.6 Whole brain pSyn quantification 
To perform a statistical quantification of pSyn staining in whole N. furzeri brain, we cut 25µm thick 
cryo-slices in series of three, processing only one whole series per animal (i.e. 25µm every 75µm of 
tissue) for pSyn and TH staining as described in the Immunofluorescence and Proteostat™ 
Aggresome staining section. We analyzed six animal per age (5w and 37w). We then acquired tiles 
at 20x using an AxioScan Zeiss microscope to obtain images of whole sections, using constant 
exposure time and applying the ‘Best Fit’ algorithm in ZenBlue. 
The whole section images were then exported as .tif files and analyzed using Adobe Photoshop as 
described as follows: 
Two copies of the image were created: 
To the first copy a blur filter was applied (Filter -> Blur Gallery -> Field Blur, applied 80px level). 
This image was applied to a second copy (Image -> Apply Image -> fusion option subtract) as a first 
background subtraction method. A threshold (value 40) was then applied to isolate the staining. 
The staining was then selected (Selection -> Color interval) and analyzed (Image -> Analysis -> 
Record Measurements) and the summary result containing the total pixel of staining per section 
was exported. 
The area of the staining was registered for each animal in an Excel file and the total stain pixels per 
brain were calculated.  
 
2.7 Central telencephalon pSyn analysis 
We used images collected with the same methodology used for the whole brain pSyn 
quantification. We analyzed six animals per age (5w and 37w). We selected the four sections 
corresponding to the most central portion of the telencephalon along the dorso-ventral axis, and 
we isolated a square of 300px x 300px (A) into the central region on each section. The images were 
analyzed with the same methodology utilized for the whole sections and the percentage of stained 












2.8 pSyn and Aggresome analysis into the Locus coeruleus 
We analyzed images of locus coeruleus acquired at a Zeiss AxioScan microscope with Apotome 
slide on a 40x magnification, all with the same exposure time and to which we applied the ‘Best 
Fit’ option in ZenBlue. We analyzed five animals per age for pSyn and four animals per age for 
Aggresome. We acquired a z-stack of the area and then analyzed the single focal plane presenting 
the majority of TH staining. We used the open license software Icy 
(http://icy.bioimageanalysis.org/) for spot analysis. To the selected z-plane we applied the 
algorithm ‘Best Thresholder’ (method ‘Otsu’) on the TH channel to isolate the locus coeruleus 
cells. Since TH is not distributed homogeneously into the cytoplasm but presents vacuolization 
containing aggregates, we adjusted manually the selected ROI to include areas containing 
aggregates. We then used the algorithm ‘Spot Detector’ imposing to perform the analysis only in 
the selected ROI with the following parameters: 
Preprocessing: red channel 
Detector: Detect bright spots over dark BG, scale 1 (for pSyn) or scale 2 (for Aggresome) 
Region of interest: ROIFixedFromSequence 
Output: export to ROI 
The ROIs created (containing the data of both the area of TH and each single spot detected) were 
exported in an excel file and the following parameters were calculated: 
-          Percentage of stained area: spots area/ TH area 
-          Mean spots abundance: number of spots / TH area 
-          Mean spot dimension: spots area / number of spots 
 
2.9 Western blot 
We performed western blot experiments to quantify the expression of Thyroxine Hydroxylase in 
the brains of MZ-222 Nothobranchius furzeri at various ages. The brains were extracted, 
immediately stored at -80° and then homogenized for 30 seconds using GelD2 buffer with addition 
of protease (cOmplete Mini, Roche) and phosphatases (PhosSTOP, Roche) inhibitors at 1x 
concentration. After centrifugation for 10 minutes at 16000 rpm, supernatant was taken, 
quantified using the BCA kit (Thermofisher) and stored at -80° for further use. 
To perform the western blot, we run 20µg of pulled protein extract derived from four samples per 
age and run them in precast gels (AnyKD Mini-Protean TGX Gels, Biorad) for 35 minutes at 100V. 
Afterwards the samples were blotted on a nitrocellulose membrane for 35 minutes at 150V. The 
membranes were then imaged with a Chemidoc XRS scanner using the Quantity one Biorad 
software and band intensity quantification was performed using the opensource ImageJ software. 







2.10 RNA-seq and proteomics data analysis 
To assess TH expression, I realized graphics of RNA expression starting from RNA-seq data derived 
from public cross-sectional experiments (Baumgart, Groth, et al., 2014; Kelmer Sacramento et al., 
2020). We combined two RNA-seq datasets of brain aging in N. furzeri: a dataset covering five time 
points (5, 12, 20, 27, and 39 weeks) and 5 biological replicates for each age and the second 
containing 4 replicates per ages: 5,12 and 39 weeks. These ages correspond to sexual maturity, 
young adult, adult (as defined by a decrease in growth rate), median lifespan and old (~30% 
survivorship) (Baumgart et al., 2014 ). In total, these represent 37 different samples spanning five 
different ages. We first normalized the samples using the Deseq2 package in the suite R and then 
divided the counts of the two datasets for the average expression of their respective 5w samples 
to be able to combine the datasets. 
We also analyzed publicly available proteomic data (Kelmer Sacramento et al., 2020). The dataset 
contains five replicates for age (5, 12, 39 weeks) and is a combination of two separate experiments 
performed utilizing tandem mass tag and analyzing the same 12w animals twice in two different 
contrasts: 39w vs 12w and 5w vs 12w. Therefore, we combined the data normalizing the protein 
expression dividing them for the mean value of the 12w animals.  
For both transcriptomics and proteomics data we performed statistical analysis calculating the 
Spearman correlation value, the pValue adjusted and the FDR to assess the statistical significance 
of the observed expression variability. 
























2.11 Establishment of organotypic cultures and immunofluorescence 
 
The following procedure was performed under a horizontal flux hood and all the instruments were 
placed under UV light for 30mins before starting the experiment. 
To perform organotypic cell culture we sacrificed 5 weeks old Nothobranchius furzeri animals by 
anesthetic overdose (Tricaine). We then immersed the whole body in 0,05% NaOH for 30s and in 
EtOH 70% for 30s to sterilize the body prior to brain extraction to reduce the probability of 
bacterial contamination of the tissue. 
Afterwards we cut the head from the body and proceeded to extract the brain under a 
stereomicroscope in a solution of Hank’s salt added with 1% Penicille-Streptomicine mixture 
(Penstrep). The extraction of the brain was performed as quickly as possible to minimize the time 
between animal death and placing of the tissue over the porous membrane; this is a critical step in 
order to reduce the death of the tissue. 
After extracting the brain, this was placed onto a micrometric slide where, with the aid of a 
microblade, coronal sections of approximatively 500 µm were cut. To obtain Locus coeruleus 
containing slices we used as anatomical reference the cerebellum and cut in front and behind it. 
After the cut the slices were gently taken with forceps and quickly immersed in three consecutive 
baths of 1% penstrep to reduce the risk of contamination and then placed on semi porous 
membrane into six well plates containing 1 ml of culture medium and kept on ice. 
We placed three brain slices onto each membrane. 
After completion of slice gathering the 6-wells were placed in an incubator at 28° and 5% CO2 and 
the medium was changed after three hours.  
In the following days the medium was changed every second day.  
Medium composition was the following: 
DMEM/F12 (Cat. 21331020, Thermofisher, USA) 
FCS 10% (Cat. ECS5000L, Euroclone, Italy) 
Sterile milliQ water 10% 
Insulin 0.033% (Cat. L9278, Merk Life SCIENCE, Germany) 
Ascorbic acid 511 µM 
PenStrep 1% (Cat. ECB3001D, Euroclone, Italy) 
Glucose to adjust the solution at 0,4%(Cat. A2494001, Thermofisher, USA)For EdU staining the 
sections were given 5µg EdU for three days starting from day one in vitro. 
After one, three or five weeks the slices were fixed in 4% PFA for 10 minutes (1ml over the 
membrane 1ml under the membrane) and then treated for immunofluorescence. 
The sections were washed in PBT (PBS plus triton 0.5%) three times and then incubated overnight 
at 4° in PBT for permeabilization. 
The following day the sections were incubated four hours in blocking solution (5%BSA, 0,5% triton, 
PBS). Afterward, the sections were gently detached from the membrane and transferred in a 12 
well to reduce the amount of primary antibody used. The slices were then incubated overnight at 
4° in primary antibody diluted in a solution of 1%BSA, 0,5%Triton in PBS.  
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The third day sections were washed three times in PBT and the incubated four hours in secondary 
antibody at RT. Sections were then rinsed and, if needed treated for EdU revelation for 30 minutes 
using the Click-it Edu Staining kit (C10337, Thermofisher Scientific, USA) and rinsed again. 









Note: Part of the following results are modified, extended and adapted from the following publications 
(complete citations for published articles and preprints are listed in the references): 
Results 3.1 (Kelmer Sacramento et al., 2020) 
Results 3.2 (Bagnoli et al., 2021), currently under review in Aging Cell 
Results 3.3 (Louka *, Bagnoli * et al., 2021) * authors have contributed equally to the paper, revised version 
ready for submission to Aging Cell 
 
3.1 Nothobranchius furzeri shows signs of protein aggregation during ageing 
 
As described in detail in our publication (Kelmer Sacramento et al., 2020), we observed an 
unbalance in mRNA and corresponding proteins level in Nothobranchius furzeri brain during 
ageing, leading to a loss of protein stoichiometry for many protein complexes which particularly 
affected the ribosome. 
Using biochemical fractionation techniques in combination with mass spectrometry in mice, we 
also observed an increase of protein aggregates SDS insoluble fractions that were also enriched in 
ribosomal proteins (Fig.1). The small dimension of the N. furzeri brains prevented us from 
performing a biochemical analysis of aggregates. To investigate age-dependent aggregation in N. 
furzeri of ribosomal proteins in killifish, I performed staining of young (7-10 weeks post hatching) 
and old (27-30 weeks post hatching) brain slices using Proteostat, an amyloid-specific dye (Shen et 
al., 2011), and LAMP1 as lysosomal marker. I detected abundant intracellular aggregates in old 
brains, but only in occasional cells in young brains. These aggregates were large in size and 
typically placed near the nucleus. Double labelling with LAPM1 revealed that these aggregates 
correspond to apparently enlarged lysosomes. The aggregates also appeared to contain the 
ribosomal protein RPS6 (Fig.1). Taken together, these data demonstrate that an age-dependent 







Fig. 1 A) Representative Coomassie-stained SDS–PAGE gel showing the isolation of SDS-insoluble aggregates from 
mouse brain lysates and quantification of the yield of SDS-insoluble aggregates from young and old brain lysates based 
on densitometry analysis of Coomassie-stained gel bands obtained from different animals, n = 5 per age group. SUP = 
supernatant, TH = total homogenate, W1 = SDS-soluble fraction, Pellet = formic acid soluble fraction. **P < 0.01, 
unpaired t-test. In boxplots, the horizontal line represents the median, the bottom, and top of the box the 25th and 
75th percentile, respectively, and the whiskers extend 1.5-fold the interquartile range. B) Volcano plot based on 
protein quantification by label-free mass spectrometry depicting the enrichment of specific proteins in protein 
aggregates. The x-axis indicates the log2 ratio between protein abundance in aggregates (Pellet) and starting total 
homogenate (TH). The horizontal dashed line indicates a P value cut-off of 0.05 and vertical lines a log2 fold change 
cut-off of ± 0.5. Selected proteins are highlighted as colored dots as indicated in the figure legend. Same volcano plot 
with ribosomal proteins enriched in mouse aggregates identified in N. furzeri aggregates highlighted in green dots.  C) 
Double labeling of telencephalic sections of Nothobranchius furzeri with anti-RPS6 (green) as ribosomal marker and 
Proteostat as a marker for aggregated proteins (red). Nuclear counterstaining was performed with DAPI (blue). Scale 
bar corresponds to10 μm. D: Magnification showing a detail of the co-localization between lysosomal structures 
















3.2 Aging is associated with a degeneration of noradrenergic-, but not dopaminergic-neurons, in 
Nothobranchius furzeri 
 
In order to investigate the possible use of Nothobranchius furzeri as a valid model to study 
neurodegeneration linked to Parkinson’s disease, I analyzed individuals from the N. furzeri 
population MZCS-222 that belongs to the same genetic clade of the population MZCS-24 studied 
by Matsui and the population MZM-0410 that has been extensively used in our group previous 
studies. This population was collected in Africa later than MZM-0410 and is therefore likely to be 
more genetically heterogeneous and closer to the wild population. The median lifespan of this 
strain in captivity is around 6 months (Žák & Reichard, 2020). 
I set out to quantify the total number of Tyrosine hydroxylase positive (TH+) cells in the Locus 
Coeruleus (LC) and in the posterior tuberculum (hypothalamus) in young (5 weeks), adult (12 
weeks) and old (37 weeks) animals to assess the presence of possible neurodegeneration. These 
age groups were chosen in order to have a clear idea of the amount of cells in the Locus coeruleus 
and posterior tuberculum throughout the life of the fish. The size of the brain increases during this 
period and the spatial distribution of cells may vary between animals of different ages (Fig. 2, 3A). 
Since at 5 weeks of age in the brain there is still a high rate of neurogenesis (Tozzini et al., 2012, 
Fig. 2), we wanted to exclude that any eventual neurodegeneration observed between young (5w) 
and old samples (37w) was due to analysis between a not fully developed nucleus and a nucleus 
with age-dependent cell reduction. Thus, we analyzed also samples from 12w of age, age in which 
the neurogenesis potential is reduced (Tozzini et al., 2012, Fig.2) and the number of cells in the 
nuclei should be definitive, at least in some brain areas. 
 
 
Fig. 2, from Tozzini et al., 2012. Panel on the left is an histogram reporting unbiased estimation of EdU+ cells into the 
tectal germinal layer at three different age-steps. Estimates for left and right tecta are reported separately. Five 
animals per time point were analyzed, and error bars represent standard deviations. The panel on the right represents 
the growth curve of N. furzeri males. The analyzed age-steps for the quantification are marked by red arrows. Forty-
five animals were measured to produce this curve. Error bars represent standard errors of means. 
 
In order to visualize and count all TH+ cells in the region of interest, we cleared the brain using the 
Sca/eS procedure (Hama et al., 2015) and reconstructed all the different TH+ nuclei of the N. 
furzeri in their entire 3D extent by scanning through the transparent brain (Fig. 3, 4). 
The N. furzeri posterior tuberculum contains two clearly separated populations of TH+ cells (Fig.5, 
panel A), one comprised of larger and more anteriorly- and dorsally located cells and one 
comprised of smaller and more posteriorly- and ventrally-located cells. These two nuclei are very 
similar to the nuclei 12 and 13 described in the zebrafish posterior tuberculum using TH 
immunofluorescence (Sallinen et al., 2009) and are proposed as homologous to the A-9 A-10 
mammalian dopaminergic cluster comprising the substantia nigra (Kaslin & Panula, 2001; Rink & 
Wullimann, 2001). I counted all cells in these two populations and could not detect a significant 
difference in their numbers between young, adult, and old animals (Fig. 5C), as opposed to the 
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remarkable    ̴50% reduction reported by Matsui et al. Notably, the number of TH+ cells we 





Fig.3 Localization of the TH+ nuclei in the brain of Nothobranchius furzeri, anterior. As the main reference for nuclei 
identification a Zebrafish map from Sallinen et al. was used. Panel A: main nuclei of the olfactory bulbs and ventral 
telencephalon (homolog to nuclei 1-2 from Sallinen et al., 2009). Panel B: caudal telencephalic nuclei and rostral 
diencephalic nuclei (homolog to nuclei 3-4 and 5-6 from Sallinen et al., 2009). Panel C: periventricular pretectal nuclei 
(homolog to nuclei 7 from Sallinen et al., 2009). Panel D: caudal telencephalic nuclei, rostral diencephalic nuclei and 
beginning of periventricular organ, Posterior tuberculum (homolog to nuclei 3-4, 5-6 and 12 from Sallinen et al., 2009). 











Fig.4 Localization of the TH+ nuclei in the brain of Nothobranchius furzeri, posterior. As the main reference for nuclei 
identification a Zebrafish map from Sallinen et al. was used. Panel A: main diencephalic nuclei of the posterior 
tuberculum: periventricular organ and periventricular hypothalamus (homolog to nuclei 12-13 from Sallinen et al., 
2009). Panel B: more caudal view of main diencephalic nuclei of the posterior tuberculum: periventricular organ and 
periventricular hypothalamus (homolog to nuclei 12-13 from Sallinen et al., 2009). Panel C: Locus coeruleus nuclei 
(homolog to nuclei 14 from Sallinen et al., 2009). Panel D: Vagal nuclei (homolog to nuclei 15-17 from Sallinen et al., 




As opposed to hypothalamic nuclei, a modest but significant decrease in the number of LC neurons 
between young and old animals (Fig. 5B, D) was detected. The reduction was not evident between 
animals at 5 weeks and 12 weeks (conversely to what observed by Matsui et al.) but seems to be 
an event occurring strictly between adulthood and old age. Also in this case, the number of 
labelled cells we detected is larger than what reported by Matsui et al.: 33 (range 37-27) vs.    ̴20 




Matsui et al. also reported a down-regulation of TH protein and transcript in the whole brain by 
Western blot and qPCR. I interrogated two independent public databases of RNA-seq (Fig. 5E) and 
one database of mass-spectrometry based proteomics of N. furzeri brain aging (Fig. 5F) and I could 
not find any support for a down-regulation of TH neither at the transcript- nor at the protein-level. 
I repeated Western blot analysis, both animals singularly and pooled, and also in this case I could 
not detect a down-regulation of TH; instead from the pulled experiment emerged a significant 
increase of whole brain TH content between 5 and 8 weeks of age. This increase is visible also 
from the single animal experiment but it did not reach statistical significancy in that setup (Fig. 5 
G, H). The increase is reflected also in the proteomic graph (Fig. 5F) although not statistically 
significant. The proteomic data seems to suggest also a reduction of the expression between 12w 
and 37w, not reflected by the western blot experiment: seen the general high variance of the 
samples at 37 weeks (shown by the errors bars in the western blot and the plot of single animals in 
the proteomic graph) and the reduced number of samples used for proteomics data (3 animals per 
age), we think that this reflects the high variability in neurodegeneration state of different 








Fig.5 Assessment of neurodegeneration in LC and posterior tuberculum and quantification of TH expression during 
ageing. A) Representative images of 3D reconstruction and cell counting in the posterior tuberculum nuclei of a young 
(5 weeks old) and old (37 weeks old) N. furzeri. V=ventral, D=dorsal, A=anterior, P=posterior. The color code indicates 
the depth of the cells in the reconstructed volume. B) Representative images of a 3D reconstruction and cell counting 
of LC of a young (5 weeks old) and old (37 weeks old) N. furzeri. V=ventral, D=dorsal, A=anterior, P=posterior. The 
color code indicates the depth of the cells in the reconstructed volume. C) cell counts of posterior tuberculum nuclei in 
young and old animals. Each open dot represents a single animal and the solid dot the mean of the group and the 
error bar the SEM. D) cell counts of LC nuclei in young and old animals. Statistically significant difference was assessed 
by unpaired Student’s t-test, n.s. indicates p > 0.05, *** indicates p < 0.001. E) Quantification of TH mRNA expression. 
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Two independent RNA-seq datasets (from Baumgart et al., 2014, and Kelmer et al., 2020) were analyzed.  F) Analysis 
of TH protein expression by mass spectrometry. We assessed a proteomic dataset (from Kelmer et al., 2020). Each 
open dot represents a single animal and the solid dot the mean of the group and the error bar the SEM. To assess the 
statistical significance of age-dependent regulation, we calculated Spearman correlation with age. In both cases p > 
0.05. G) Images of TH protein expression by Western blot, A total of four animals per each age were analyzed, 
independently or pulled. H) Quantification of TH Western blot. The intensity of TH band was normalized with respect 
to the tubulin band. To assess statistical significance, we calculated Pearson’s correlation coefficient of the expression 
with age and respective pValue, the data are expressed as mean ±SEM.  
 
To assess pathological post-translational modifications of α-Syn, I used an antibody directed 
against phosphorylated S129 (pS129) in double-labelling with TH.  
N. furzeri α-Synuclein aminoacid sequence presents a substitution of the serine located at the 
residue 129, involved in phosphorylation, with a threonine (Fig.6). Since threonine is a 
phosphorylable aminoacid, and the vast majority of kinases present in the cell are serine-
threonine kinase (included the ones responsible for α-Syn phosphorilation, Waxman & Giasson, 
2011), coupled with the fact that the immediately adjacent amminoacids to the Tre129 of N. 
furzeri are conserved with the human sequence, we assume that Tre129 can be phosphorylated 




Fig 6. Alignment of human and N. furzeri α-Syn. Highlighted is the Ser129Tre aminoacid substitution with the adjacent 
aminoacids conserved. 
 
Labelling of posterior tuberculum neurons did not reveal any somatic staining for pS129 in either 
young (5 weeks) or old (37 weeks) samples (Figure 8A). On the contrary, a punctate labelling of 
pS129 was readily detected in the LC neurons from old fish (Fig.7B). Remarkably, LC TH+ neurons 
contained punctate labelling of pS129 already at young age (Fig.7A). The only other cells showing 
early somatic labelling in the brain were TH+ cells in the vagal nuclei (Figure 8B). Quantitative 
analysis of the staining revealed that the size of pS129+ puncta increased between young and old 
animals (Fig.7C-E), while their number does not increase in a statistically significant way. It should 
be noted that the cytoplasm of LC neurons in old animals shows a clear vacuolization, apparent as 
spherules devoid of TH immunoreactivity (Fig. 7Bb). Interestingly, pS129+ puncta are not present 















Fig.7 Double immunofluorescence for TH (green) and phospho-Synuclein (red) in locus coeruleus cells. A diffuse, 
punctate staining (white harrowheads) is visible in both young (5w, panel A,a) and old (37w, panel B,b) animals. Please 
note in the magnification shown in panel b the presence of cytoplasmic vacuoles. The dimension (panel C) and the 
area (Panel E) of the puncta increases significantly with age. To test significance two tailed unpaired t-test was used, 







Fig.8 TH (green) and phospho-Synuclein (red) staining in posterior tuberculum (hypothalamus) and vagal nuclei. 
Phospho-Synuclein staining was absent from hypothalamic cell bodies both at young (5w, panel A) and old age (37w, 
panel B), while a somatic, punctate staining was present already at young age (5w, panels C,c) in cell bodies located in 
the vagal nuclei and remained evident also in old animals (37w, panels D,d). In panel C scale bar corresponds to 100 




I also assessed a general increase of pS129 staining in the whole brain and in the central 
telencephalon specifically (Fig. 9A, B), this region was chosen because age-dependent appearance 
of protein aggregates was previously demonstrated by us (Kelmer et al., 2020). Labelling outside 
of the LC was observed mostly in the form of labelled processes and, unlike in the LC and vagal 
nuclei, clearly labelled somata with punctuate labelling could not be detected. Both the total brain 
area covered by pS129 labelling and the density of labelling in the telencephalon were increased in 
old animals (Fig.9C, D). Remarkably, pS129 in the telencephalon appeared to be associated, albeit 
not exclusively, to TH+ positive axonal fibers (Fig.9E). These dystrophic axons may originate from 




Fig.9 Phospho-Synuclein staining in other brain areas. I quantified the amount of phospho-Synuclein staining in the 
whole brain of young (5w panel A) and old (37w panel B) animals and we found a significant increase with ageing 
(panel C). I also focalized the analysis in the central telencephalon (panels a’, b’). Also in this area we found a statistical 
significant increase of phospho-Synuclein staining (panel D). To test significance two tailed t-test was used, ** = 
p<0.01 and *** = p<0.001, the data are expressed as mean ±SEM. 
Apart from locus coeruleus and vagal cells, the staining of phospho-Synuclein is localized in processes, not exclusively 
colocalizing with TH positive fibers. We were able to find such staining associated with TH positive processes especially 






In addition, I investigated the presence of protein aggregates (aggresomes) in LC neurons from old 
fish.  The Proteostat dye revealed a punctate staining in TH+ neurons from old, but not young fish 
(Fig. 10 A, B). This difference was apparent and was also confirmed by quantitative analysis (Fig.10 
C-E).  The localization of aggresomes in LC neurons was distinct from that of pS129 puncta, as 




Fig.10 Double immunofluorescence for TH (green) and Aggregates (Proteostat Aggresome Dye, red) in locus coeruleus 
cells. Aggresome staining is absent in young animals (5w, panel A) and becomes visible in old animals (37w, panel B). 
In particular, aggregates are mainly located in vacuolized areas of cytoplasm devoid of TH staining (panels, b’, b’’, b’’’) 
that are not present in young animals (panel a). The area (panel C), the number (panel D) and the dimension (panel E) 
of the aggregates all increased significantly with ageing. To test significance two tailed t-test was used, * = p<0.05 and 






3.3 TDP-43 undergoes a change of distribution during ageing in Nothobranchius furzeri 
 
Since TDP-43 is another protein associated with neurodegeneration and age-dependent 
neurodegenerative diseases, we decided to check its cellular distribution and possible aggregation 
during ageing in Nothobranchius furzeri. In our work realized in collaboration with the group of 
prof. Annalisa Pastore at the King’s college in London, we describe how the N. furzeri TDP-43 
protein shows aggregation characteristics similar to the human isoform in vitro (Louka et al., 
2021). 
Seen these interesting first observations, I probed the localization of the protein distribution 
throughout the principal areas of the fish brain, such as telencephalon and optic tectum 
performing immunofluorescence experiments on 25 mm cryo-sections of N. furzeri MZM-04010 
brains, to assess N. furzeri TDP-43 localization during ageing in vivo. I compared animals at 5 
weeks, the age at which the animal reaches maturity, with animals at 27 weeks, when age-
dependent mortality starts (Terzibasi et al., 2008). To verify the robustness of the staining pattern, 
we used two different antibodies raised against the human protein with different epitope 
specificities: a monoclonal (Abcam) and a polyclonal (Proteintech) rabbit antibody, respectively. 
The two different antibodies showed comparable staining patterns (Figure 11) but the monoclonal 
antibody showed an overall cleaner signal, which was also more stable over prolonged storage. 
The staining associated with the polyclonal antibody was instead labile and decayed in a few days. 
For this reason, we decided to use the monoclonal antibody in all further experiments. 
TDP-43 staining showed a variable level of diffuse expression in the cell nuclei of young animals 
(Fig. 11A, B), presenting cells with brighter signal (white arrowheads), and others with a less 
intense TDP-43 positivity (white arrows). Staining in old tissues was characterized by the presence 
of cells with a peculiar endo-perinuclear concentration of protein labelling (Fig. 11C, D, doughnut-
like stained cells, red arrowheads). Doughnut-like stained cells were sporadically present in the 
young animals (data not shown). This fact, together with the presence of cells with diffuse 
labelling in the old tissue, suggested that the altered protein distribution has a progressive 
evolution over time. 
 
 
Fig. 11: Immunostaining of TDP-43 with monoclonal (A/C) and polyclonal antibody (B/D).  The staining resulted quite 
comparable in both cases with the presence of cells showing a more intense labelling (white arrowheads) and other 
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with a less strong signal (white arrows). Both staining highlighted the presence of doughnut-like cells especially in old 
samples (panels C/D, red arrowheads). Sale bar indicates 10 µm. 
 
To better appreciate the doughnut-like TDP-43 distribution in old animals, I performed whole mount 
brain staining (Fig.12): I cleared and stained whole N. furzeri brains, by using a Sca/eS 
immunofluorescence-optimized methodology (AbSca/e) (Hama et al., 2015), and registered 3D 
brain reconstructions by acquiring confocal serial stack images and processing them through the 
IMARIS Software. By comparison of the 3D representations of the tissues from young (Fig.12 Aa) 
and old (Fig.12 Bb) animals, we observed an apparently higher proportion of doughnut-like cells (red 
arrowheads) in the telencephalic area of the old fishes as compared to that of the young ones. 




Fig. 12: Whole mount staining of TDP-43 in Nothobranchius furzeri brains. Using AbSca/e clarification protocol we 
were able to observe TDP-43 expression in whole mount brains of young and old Nothobranchius furzeri. In this 
images telencephalic regions are shown and it is clear how the number of doughnut-like cells (red arrowheads) is 








To assess the precise subcellular localization of TDP-43, I run a double immunofluorescence with 
Nup, an antibody against the nucleoporin complex (Fig.13). I was able to identify doughnut-like 
cells in all brain major areas (telencephalon, optic tectum, cerebellum and rhombencephalon). The 
localization of TDP-43 appears mainly intranuclear, with the rest cytoplasmatic in close proximity 






Fig. 13  : Subcellular localization of TDP-43 in doughnut-like cells. We were able to find presence of doughnut-like cell 
in all major brain areas of old animals. The majority of TDP-43 stain in these cells is located internally to the nuclear 
envelope as highlighted by the white circle drawn around Nup (Nucleoporin) staining. The rest of TDP-43 staining is 
cytoplasmatic, partially located in close proximity to the nuclear envelope. Tel= telencephalon, TO= optic tectum, Crb= 
cerebellum, Rom= rhombencephalon. Scalebars indicates 2 µm in the first row and 5 µm in all the others. 
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I then performed a double staining, by combining TDP-43 immunofluorescence (Fig. 14, 15 green) 
with the Aggresome dye (Fig. 14, 15 red), to discriminate between generic protein aggregates and 
specific TDP-43 aggregates, visualized as co-localized green-red fluorescent dots. Comparison of 
sections from young and old brain tissues showed the presence of several double stained TDP-43 
granules in the old tissue (Fig. 14B, b red arrowheads). Some of the granules were strictly 
associated to doughnut-like cells. In contrast, consistent with our previous results (Kelmer 
Sacramento et al., 2020) we were unable to detect aggregates in the young brain tissue, either 
with or without TDP-43 staining (Fig.14 A). The red fluorescent signal detectable in the young 
tissue was not a specific Aggresome staining, but it was to ascribe to auto-fluorescent blood 
vessels and erythrocyte cells as it is evident in all fluorescent channels. 
These results demonstrate that it is possible to follow ageing-related aggregation of TDP-43 in N. 
furzeri mimicking the neuronal alterations typical of ALS/FTD and supported the killifish as a 
convenient model of TDP-43 aggregation in vertebrates with compressed lifespan. 
 
 
Fig. 14:  Immunostaining of TDP-43 and colocalization with protein aggregates in old versus young Nothobranchius 
furzeri brains. Protein aggregates were stained using aggresome dye (red), while TDP-43 was labelled with the 
monoclonal antibody (green). Both in telencephalon (panels A/B) and optic tectum (panels C/D) we were able to 
observe aggregates presence in old brains only (panels B/D) while no trace of aggregation was detectable in young 
samples (panels A/C). Moreover, TDP-43 staining often colocalize with aggregates signaling, and such aggregates 
appear to be localized mainly near doughnut-like cells (b/d magnifications, red arrowheads). White arrowheads in 







Fig.15 High resolution images of TDP-43 in aggregates. We were not able to find signs of aggregation in young animals. 
In old animals some aggregate colocalize with TDP-43 (white arrow). The z represents four consecutive planes 
acquired along the z axis, each acquired at 1µm step from the previous. Scale bars indicate 2 µm. 
 
Seen the interesting relationship between TDP-43, stress granules and aggregation discussed in the 
introduction, I investigated the possible co-localization of TDP-43 with stress granules in N. furzeri 
tissues. To do so, I performed double immunostaining for furzeri TDP-43 and G3BP, a core protein 
of the stress granules often used as a marker (Martin & Tazi, 2014). The labelling for G3BP was more 
widespread than that of TDP-43 both in telencephalon and optic tectum, being the signal distributed 
widely in the cytoplasm of the majority of cells (Fig. 16). We were nonetheless able to observe the 
presence of granular structures double-labelled for G3BP and TDP-43 in samples of both young and 
old animals. This evidence supports the idea that a TDP-43 involvement in stress granules formation 
and regulation is conserved in N. furzeri. Even more importantly, the amount of granules containing 
TDP-43 inclusions seemed to be greater in the samples from old animals (Fig.16 insert, white 
arrowheads, Fig.17). This is consistent with the idea of an increase of stressing conditions during 
ageing and thus an increased formation of stress granules inside the cell. Accurate quantification of 
this visible difference was not attempted for the time being. 




Fig. 16: Immunostaining and colocalization of TDP-43 (green) and G3BP (red). We were able to observe several cells 
showing partial overlapping signal between TDP-43 and G3BP (white arrowheads), used here as Stress Granules 





Fig.17: High resolution images of localization of TDP-43 in stress granules (SG). We found presence of SG both in young 
and old samples. Some SG colocalize with TDP-43 (white arrows). The ones not colocalizing (red arrows) are located in 





3.4 Establishment of N. furzeri brain organotypic cultures to study ageing ex-vivo 
 
To perform long term culturing, I operated in strictly sterile conditions under a hood (Fig. 18) to 
extract the brain of young (5-weeks old) fish and I manually cut coronal slices of approximatively 
500µm width with the aid of a micro-knife and a micrometric slide (Fig. 19). The slices were then 
immersed briefly (1-2s) in three consecutive wash of antibiotics (Pen-strep 1%) to maintain 
sterility of the tissue and gently placed onto a semipermeable membrane located into a six well 
plate (Fig. 19). The slices were then incubated at 27°C with a CO2 tension of 5%, and an ad-hoc 





Fig.18: Experimental setup for organotypic slice preparation. All procedures were performed under a sterile horizontal 






Fig.19: Organotypic slices cut and placement. Extracted N. furzeri brains are placed on a micrometric slide and 
approximately 500µm thick slices are cut. After three washes in Pen-Strep, the slices are carefully laid onto the 
semiporous membrane inserted into a six well plate containing the culturing medium. Slices were cut from 
Telencephalon (Tel), Optic tectum (OT), and Cerebellum (Crb). 
 
Slices were obtained from telencephalon, mid-brain/optic tectum and hindbrain/cerebellum (Fig. 
19). Viability of slices was inspected visually during regular medium changes. Healthy brain slices 
become thinner and spread over the surface becoming attached and more translucent after a 
couple of days in culture. Slices that acquire a milky-white appearance and fail to attach to the 
membrane were discarded. Moreover, the macroscopic structure of the tissue could be easily 
recognized utilizing an inverted microscope in healthy slices (Fig. 20). 
 
 
Fig.20: Examples of organotypic slices of cerebellar-pontine area (panel A) and optic tectum area (panel B) at 1 day in 
vitro and 1 week in vitro. 
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To assess neuronal survival, I performed whole-mount immunofluorescence on slices cultured for 
different times (wiv: weeks in vitro). Specifically, I decided to assess preservation of the Locus 
coeruleus in cerebellar-pontine slices, taking advantage of the ease in isolating the anatomic area 
containing this nucleus (i.e., taking as point of reference for the cut the anterior and posterior 
margins of the cerebellum) and of the already well-tested immunofluorescence procedure for TH. 
I observed slices at 1wiv, 3wiv and 5wiv and in all three time points I was able to observe 
fluorescence signal identifiable as Locus coeruleus cells (Fig. 21,22), demonstrating that these cells 
were able to survive up to 5wiv in healthy-looking slices. I initially cultured 6 slices per 
experimental group, unfortunately though, the number of slices that survived was too low to allow 























































Fig.22: Examples of Locus coeruleus cells imaged from N. furzeri organotypic slices of 5w old animals after 1, 3 or 5wiv. 
Anatomical reference modified from D’Angelo 2013, in red highlighted the area of imaging. D=dorsal, V=ventral, 
L=lateral, M=medial. Scale bar indicates 100 µm. 
 
 
Adult neurogenesis is widespread in the killifish brain (Tozzini et al., 2012). I decided to analyze 
adult neurogenesis in optic tectum and telencephalon using EdU staining. EdU is a thymine analog 
that is incorporated in the DNA during replication and can be easily visualized in tissue slices. EdU 
was previously used in my group to identify adult neurogenic niches in N. furzeri (Tozzini et al., 
2020). In order to do so, EdU at a concentration of 5µg/ml was administered for three consecutive 
days starting from 1div (div: days in vitro) and then samples were analyzed at 3wiv and 5wiv (Fig. 
23). In both cases, I was able to observe EdU staining. To label the neurogenic niches, I used PCNA 
as a marker (Tozzini et al., 2012). The EdU positive cells are displaced from the PCNA positive area; 
this phenomenon is also visible in vivo (Tozzini et al., 2012), and indicates that, after their terminal 
division, the EdU cells have survived for at least five weeks. This observation leads to the 
conclusion that also in organotypic slices, the tissue is able to grow and organize in similar fashion 










Fig.23: Optic tectum organotypic slices from 5weeks old animals at 3viw. I was able to perform PCNA and EdU staining 
and migration of EdU stained cells apart from the PCNA positive is clearly visible. Scale bars indicates 100 µm on the 
first row and 200 µm on the second row. 
 
I also tried to perform organotypic culturing of tissues taken from old animals (30 weeks of age). 
Also in this case, I performed immunofluorescence for TH in cerebellar-pontine slices and EdU 
staining in optic tectum and telencephalic slices.  
I started from 6 slice per group but, having utilized much older tissues their survival was greatly 
reduced; pontine-cerebellar slices lasted in culture approximately two weeks before starting to 
show signs of degeneration. At the end only 2 slices per group were in good enough state to be 
imaged. 
Again, I was able to observe Locus coeruleus cells also in old tissues after 2wiv (Fig. 24) and I was 
able to observe and identify neurogenic niches as observed from in vivo tissues (Fig. 25). 
The results showed in this section are obtained from my first attempt at culturing organotypic 
slices. Therefore, there is still the need to optimize the technique and attempt again these 



































Fig.24 Example of Locus coeruleus cells (white arrowheads) in N. furzeri organotypic slices taken from 30w old 
individuals and imaged after 2 wiv. Anatomical reference modified from D’Angelo 2013, in red highlighted the area of 






























Fig.25 Optic tectum and Telencephalon organotypic slices from 30w old animals maintenance of adult neurogenic 
niches. On top row an optic tectum slice and comparison with neurogenic niches observed in vivo (modified from 
Tozzini et al., 2012, anatomical reference form D’Angelo 2013). In red is highlighted the correspondent area observed 
in the organotypic slices. On bottom row examples of a telencephalic organotypic slice and comparison with the 
corresponding neurogenic niches observed in vivo (modified from Tozzini et al., 2012, anatomical reference form 














In this thesis, I present data indicating that teleost Nothobranchius furzeri is a pertinent model to 
study physiological protein aggregation in the aging brain as well as aggregation of disease-related 
proteins. 
I first showed that protein aggregates colocalizing with lysosomal markers accumulate with ageing 
in N. furzeri and contain ribosomal proteins. I then analyzed specific protein aggregate that are 
related to neurodegenerative diseases, like PD and FTD. I observed that some aspects of these 
diseases, that normally require genetic or toxicological interventions to be modelled in rodents or 
teleost, can be observed spontaneously during N. furzeri aging. Specifically, neurodegeneration 
and presence of pS129 immunoreactivity was observed in cell bodies of the Locus coeruleus, one 
of the areas that are preciously affected by PD in humans, and an increase of abnormal 
distribution of TDP-43 surrounding the nuclear envelop, reflecting some aspects of human 
pathological TDP-43 behavior. Finally, I developed an organotypic culture protocol to exploit the 
rapid physiological ageing of Nothobranchius enabling ex vivo studies of age-associated 
phenotypes in the brain. 
The combination of these results clearly establishes N. furzeri as an experimental model of age-
dependent protein aggregation.  
 
Note: Part of the following discussion is modified, expanded and adapted from the following publications 
(complete citations for published articles and preprints are listed in the references): 
Discussion 4.1 (Kelmer Sacramento et al., 2020) 
Discussion 4.2 (Bagnoli et al., 2021), currently under review in Aging Cell  
Discussion 4.3 (Louka *, Bagnoli * et al., 2021) * authors have contributed equally to the paper, revised 


























4.1 Aggregates enriched in ribosomes forms during N. furzeri ageing 
 
In our paper (Kelmer Sacramento et al., 2020), we showed that protein aggregates accumulate 
with age in mouse brain lysates as shown by biochemical fractionation and purification of SDS-
insoluble precipitates. Enrichment for ribosomal proteins in aggregates was then detected using 
mass-spectroscopy based proteomics. I confirmed these data using staining techniques on brain 
sections.  Firstly, I used a general fluorescent staining for aggregated proteins, and this revealed 
the presence of large intracellular aggregates in the telencephalon. These aggregates colocalized 
with lysosomal markers and therefore were likely the result of a failure of lysosomal degradation. 
Many different lines of evidence point to a lysosomal dysfunction in aging (Colacurcio & Nixon, 
2016; Glaser et al., 1994; Nixon, 2020). Lipofuscin, an autofluorescent form of aggregates, is a 
universal marker of aging and it is known to accumulate in lysosomes. Up-regulation of transcripts 
coding for lysosomal proteins is a highly-reproducible transcriptional marker of aging (Aramillo 
Irizar et al., 2018; de Magalhães et al., 2009). This regulation likely represents an abortive 
compensatory response since lysosomal pH increases with age impairing proteolytic activity 
(Nixon, 2020) and we observed a stochiometric imbalance in the components of the V-type 
ATPase that certainly impairs its function (Kelmer et al., 2020).  
To confirm that aggregation of ribosomal proteins in N. furzeri, I performed immunofluorescence 
analysis that revealed presence of aggregates in old tissues that resulted positive for RPS6 protein. 
It was recently shown that aggregates of disease related proteins such as Tau and Huntingtin are 
heterogeneous and contain ribosomal proteins (S. Banerjee et al., 2020; Gruber et al., 2018) and 
that ribosome aggregation can be induced also by acute injury such as ischemia (F. Zhang et al., 
2006). On the other hand, impaired protein synthesis is a recognized early marker of 
neurodegeneration (Halliday et al., 2015; Radford et al., 2015). Therefore, ribosomal impairment 
and aggregation delineate yet another link between normal aging and neurodegeneration. It is 
already well established that loss of proteostasis is one of the main features of ageing (Alavez et 
al., 2011; Kaushik & Cuervo, 2015; Ray, 2017) and how this is also strictly related to 
neurodegenerative diseases (Cox et al., 2020; Francisco et al., 2020; Hou et al., 2019). The 
ribosome translational machinery is obviously a pivotal point in the production and maintenance 
of protein balance and therefore a loss of its stoichiometry and/or its sequestration in aggregates 
could lead to an inevitable imbalance of proteostasis. Moreover, ribosomal proteins are the most 
abundant proteins in the cytoplasm (Beck et al., 2011) and an imbalance in their synthesis and 
homeostasis has an impact on the entire energy state of the neurons.  
The conservation of this process between mice and Nothobranchius furzeri could thus be used as a 
foundation to justify the attempt at using this novel animal model to study further aggregation 
and aggregation-related pathologies, taking particular advantage of the short life duration of N. 
furzeri, allowing us to analyze the relationship between ageing, aggregation and 












4.2 Parkinson-like pathology in N. furzeri 
 
In our paper (Bagnoli et al., 2021 under review), we report an age-dependent degeneration of 
noradrenergic neurons in the Locus coeruleus, but not of dopaminergic neurons in the posterior 
tuberculum, a brain region supposed to be the homolog of mammalian A8 and A9 dopaminergic 
populations. The results of my analysis contrasts with the results of a recent paper by Matsui et al. 
(Matsui et al., 2019) who report loss of noradrenergic and dopaminergic neurons in N. furzeri and 
a down-regulation of TH expression in homogenates from the whole brain. Two main factors may 
account for this discrepancy. In the first place, I used a different counting method and instead of 
counting cells in thick sections, I clarified the entire brain and reconstructed the nuclei of interest 
in their entire 3D extent. Since N. furzeri brain grows considerably during adult life and cells 
belonging to the posterior tuberculum shift and distribute along the rostro-caudal axis accordingly, 
it may be possible that a sampling protocol that identifies all cells in young animals may under 
sample the same cells in older animals. Indeed, my 3D reconstructions show that dopaminergic 
neurons of the posterior tuberculum are more widespread in brains from old fish.  A second 
possibility is the existence of genetic differences between the two strains. Even if the population 
MZCS-222 we analyzed here and the population MZCS-24 analyzed by Matsui et al. are part of the 
same genetic clades and the distance between the two collection points is around 50 km (Cellerino 
et al., 2016), it cannot be formally excluded that the subtle genetic differences between the two 
stocks may have an impact on dopaminergic neuron maintenance. Lacking access to the 
population MZCS-24, I cannot exclude this possibility. Yet, our results exclude that degeneration of 
dopaminergic neurons is a general trait of wild-type N. furzeri. 
To assess whole brain TH abundance Matsui et al. showed Western Blot data from pooled animals, 
while in our study I report both the results of individual and pooled samples and the results are 
supported also by non-targeted approaches such as RNA-seq and Mass-spectrometry based 
proteomics. I did not find any evidence for a down-regulation of TH expression, instead I found 
indications of an increase of TH abundance concentrated between 5 and 8 weeks of age. This can 
be explained with the growth of the body and brain size of the fish, together with the still high rate 
of neurogenesis present in this timeframe (Tozzini et al., 2012 and Results Fig. 2); it is thus 
reasonable to think that areas containing a very high number of TH+ cells such as olfactory bulb 
(Results, Fig. 3) and vagal nuclei (Results, Fig. 4) are still susceptible to an increase during this 
growth phase. Conversely areas containing a relatively low quantity of TH+ cells such as LC and 
posterior tuberculum seem to have already reached their full growth in terms of TH+ cell 
abundance at 5 weeks of age as indicated by absence of increase of cell number of such areas 
between 5 and 12 weeks of age (results, figure 5C). The lack of statistically significant reduction of 
TH protein expression in old age can be explained with the same reasoning: the presence of a 
large number of TH+ cells in other brain regions would make the impact of a specific loss of LC and 
posterior tuberculum neurons negligible on the abundance of TH in the whole brain. 
Neurodegeneration is associated with accumulation of the pathogenic post-translational 
modification pS129  (Samuel et al., 2016). The condition we describe, with accumulation of pS129 
is reminiscent of the prodromic, pre-symptomatic stages of PD as described by (Forno et al., 1969, 
Braak et al., 2003, Dickson et al., 2008) that show staining with α-Syn in the vagal nuclei and Locus 
coeruleus that precedes the degeneration of dopaminergic neurons and the onset of motor 
symptoms. Recently, it has been proposed that liquid-liquid phase separation could be the initial 
mechanism of α-Syn nucleation, and it has been demonstrated in vitro how a phosphomimetic 
mutation (S129E) increases the rate of liquid-droplet formation and reduces the critical 
concentration of protein required for the beginning of the phase separation (Ray et al., 2020), in 
accordance with the notion that phosphorylation of Serine 129 site is critical for aggregation of α-
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Syn (Samuel et al., 2016). In our case, I was not able to observe the canonical Lewy body 
formations inside Locus coeruleus cell bodies, but what I observed is reminiscent of what is 
described in phase liquid-liquid separation studies; the pS129 staining is indeed punctuate and 
very disperse in all cytoplasm, moreover its staining does not overlap with aggresome staining, 
supporting further the hypothesis that this state may correspond to an initial conformation change 
that precedes the formation of aggregates. 
In summary, from my observations, N. furzeri shows a condition that is more reminiscent of the 
presymptomatic stage of PD than the full blown out pathology. This is somewhat expected since 
the animal I have used are ‘normal ageing’ animals and have not been selected based on particular 
phenotypic evidence. This reflects also what is observed in humans; not all humans showing Lewy 
body or α-Syn aggregation are affected by PD (Dickson et al., 2008; Forno, 1969; Fumimura et al., 
2007), and this suggests that indeed for PD, but reasonably for most neurodegenerative diseases, 
the definition of pathology is strictly related to symptoms appearance and  those become evident 
only after a certain threshold of damage/aggregation/neurodegeneration has already occurred in 
the brain. We therefore should be very careful on defining pathology based only on 
histopathological signs, and we should take in great consideration also eventual behavioral signs. 
However, these considerations should not refrain us to study early stages of aggregation and 
neurodegeneration. Even if these signs are not sufficient to be considered pathological without 
the presence of other functional symptoms, is indeed undeniable that those are the first steps 
toward the development of the pathology itself. Moreover, the initial phases leading to 
neurodegenerative diseases are the less known since, in humans, studies are performed only after 
the emergence of the symptoms or on postmortem samples, when the disease is already 
established, and animal models often use toxic agents or uncontrolled overexpression of mutated 
genes to achieve pathological or behavioral signs somewhat reminiscent of human pathology. 
Therefore, analyzing how aggregation begins, how it worsens and become pathological is of 
extreme relevance.  In this aspect, N. furzeri could represent the perfect model to study the 
emergence of aggregation and neurodegeneration, and to identify modifying factors responsible 
for pathological transition, being short-lived, having an ageing process highly conserved with that 
of mammals and being at the interface between ageing-related pathology development and 





















4.3 TDP-43 age-dependent aggregation in Nothobranchius furzeri 
 
In our manuscript (Louka, Bagnoli et al., 2021 under review), we laid the foundations for the use of 
N. furzeri as a new animal model to follow the age-dependent aggregation of TDP-43.  
In silico and in vitro analysis conducted on the purified N. furzeri TDP-43 showed and supported 
that the properties of nucleocytoplasmic transport, RNA and DNA binding and phase separation 
should be conserved. We also observed that the C-terminus has a strong  tendency to aggregate in 
agreement with what has been observed for the human protein (Capitini et al., 2020; Vega et al., 
2019). 
If proteins from organisms as far apart as human and killifish retain a similar tendency to 
aggregate and misfold, the property must be inherent to the protein and its function. 
In parallel to these in silico and in vitro studies conducted by our collaborators, I carried out an ex 
vivo investigation in animal tissues to test whether TDP-43 can form aggregates also in the animal 
and/or behaves differently in young and old fishes. Using immunofluorescence experiments, I 
proved that furzeri cells may show an abnormal distribution of nuclear TDP-43 (doughnut-like 
cells) that increases markedly during ageing. This could be interpreted as a sign of impaired 
nucleocytoplasmic transport, which does not come as a surprise since dysfunction of 
nucleocytoplasmic transport is often associated to neurodegenerative diseases and is also 
observed in physiological ageing (Hutten & Dormann, 2020). TDP-43 neurotoxicity in 
neurodegenerative disorders could thus be linked to a loss of function of nuclear TDP-43 (Xu, 
2012) and, more in general, to dysfunction of nucleocytoplasmic transport. 
I was then able to observe protein aggregates exclusively in old brain tissues as expected from our 
previous results (Kelmer Sacramento et al., 2020). Some of these aggregates were positive to TDP-
43 staining and strictly associated to doughnut-like cells. This behavior, summed to my other 
observations, allows me to conclude that N. furzeri is indeed able to form intracellular pathological 
aggregates in vivo and strengthened the interpretation of doughnut-like cells as a pathological 
condition that can, in the future, be used as a marker to identify aged animals. 
I also demonstrated co-localization of TDP-43 and G3BP, both in young and old animals, 
confirming that the interaction between TDP-43 and stress granules is a common feature also in N. 
furzeri. It has been shown that stress granules impair nucleocytoplasmic transport and that 
suppression of stress granules prevents neurodegeneration in a ALS/FTD model based on C9ORF72 
gene mutation(K. Zhang et al., 2018). This observation suggests that, by preventing access of TDP-
43 to the nucleus, stress granule formation may be central to the pathogenic mechanisms of ALS. 
It will thus be of great interest to study such interactions further in this animal model and find 
ways to link stress granule dynamics dysregulation with TDP-43 related neurodegenerative 
diseases. 
In conclusion, our results clearly demonstrate the feasibility of using N. furzeri as a powerful model 
for TDP-43-related diseases, exploiting the advantages of the short lifespan of this organism, 
within the limitations intrinsic in any model. Further studies will be needed to observe the TDP-43-
related ageing process in N. furzeri in a more temporally and spatially defined manner and 










4.4 Establishment of organotypic cultures in Nothobranchius furzeri 
 
Organotypic culture is an undoubtedly useful technique that recollects the advantages of both in 
vitro and in vivo experiments. This has been extensively used to study rodents and also partially to 
perform studies regarding the central nervous system (retina) in zebrafish. But adapting this 
technique in Nothobranchius furzeri could lead to advantages unthinkable in other species. Seen 
the considerable short life of this model, it is reasonable that even a relatively short time of 
culturing as long as 5 weeks could lead to an ‘in vitro ageing’ process similar to what is observed in 
vivo between 5 weeks and 10 weeks of age. This prospect, if correct, can lead to a whole new set 
of experiments and analysis that can be easily performed ex vivo avoiding much of the problems 
and complications of performing the same procedures in vivo, such as, for example, drug testing.  
To be able to cultivate thick brain slices long-term, I adapted mediums already present in 
literature, putting particular care in the osmotic balance adjustment increasing the glucose 
concentration of the basal MDM-F12 medium to 0,4% and diluting the complete medium by 
adding 10% of water. The other medium components were relatively basic, including Ascorbic 
acid, insulin, Fetal Calf Serum (FCS) and Pen-Strep. The main reason behind the relatively basic 
composition of the medium lays in the assumption that, cultivating thick portions of tissues, the 
slices should be able to maintain and produce a functional microenvironment without much of 
intervention from outside medium, thus I focused mainly on supplying nutrients. Of course, the 
medium and the slice viability could be further improved via testing of other components added to 
the basal composition but, for the scope of my thesis and for the first implementation of this 
technique in a new animal model, I put more of my effort in developing the correct procedure, 
leaving the perfectioning of the medium for future studies. In the end I was to realize slices from 
both young (5 weeks) and old (30 weeks) animals and to cultivate the tissues for as long as 5 
weeks in vitro. This, although preliminary, is a very promising result. Indeed, the anatomical 
integrity of the slices is maintained (results, Fig. 20) and also immunofluorescence staining 
revealed the maintenance of cellular distribution characteristics. 
I was able to perform immunofluorescence staining of Locus coeruleus cells in cerebellar-pontine 
slices extracted from 5 weeks old animals and maintained in culture up to 5wiv, showing that the 
tissue survived, and the cells did not degenerate completely. Moreover, I was able to perform Edu 
and PCNA staining and imaging with very good results in optic tectum-derived slices, identifying a 
shift in the EdU staining from the PCNA positive area that can be interpreted with the ability of the 
slices to grow and, possibly, to differentiate new neurons even if this possibility should be 
addressed with further experiments (e.g., staining of new neurons with EdU and HuC/D).  
I also tried to cultivate slices extracted from 30 weeks old animals. The viability of these tissues 
was greatly reduced as expected, but I was able nonetheless to perform immunofluorescence and 
identify again Locus coeruleus cells in the cerebellar-pontine slices, while also being able to image 
and recognize adult neurogenic niches in optic tectum and telencephalic slices. The observed 
neurogenic niches showed a great resemblance with the niches observed in vivo (Tozzini et al., 
2012, results Fig. 25) proving further that the structural architecture of the slices is maintained 
during the culturing time. 
Even if the results presented are very preliminary and more intensive studies are going to be 
performed, they can be of extreme importance in recognizing the possibility of organotypic slice 
culturing in Nothobranchius furzeri. Elsewhere in this thesis I already have addressed how the 
short lifespan of this animal model can be crucial to advance our understanding of ageing process 
and ageing-related pathologies. Thus, developing also an in vitro protocol to combine the fast 
ageing of Nothobranchius with the easy manipulation of in vitro samples could represent a 
winning strategy to address important questions. I firmly believe that establishing organotypic 
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culture of this animal could represent an important step in the advancement of our knowledge of 


















































With my work, I addressed whether the teleost Nothobranchius furzeri could be used to study age-
related diseases, focusing in particular on neurodegenerative diseases. The study of these 
pathology is of great relevance, since their impact is so great on our society and, despite all efforts, 
a definitive cure to these pathologies has yet to be found. Many animal models have been 
employed to try to address these imposing problems but all of them have as main drawback the 
long lifespan that led scientist to someway push the manifestation of the disease in young animals 
through use of toxic agents or strong mutated genes expression. Even if these methodologies have 
been useful in understanding many aspects of neurodegenerative diseases, they represent a 
situation that is very different from the slow progressing, age-related accumulation of aggregation 
and other pathologic factors observed in humans. Thus, using a model that recapitulates the main 
signs of mammalian ageing and presents a short lifespan could improve our current 
understandings of age-related pathologies. 
I showed with my work, and with the work of my collaborators, that Nothobranchius furzeri brain 
accumulates aggregates during ageing, and those aggregates are particularly enriched in ribosomal 
proteins. The sequestration of ribosome components can lead to and worsen the proteostasis 
unbalance that is a common characteristic of both ageing and neurodegenerative diseases, and 
this observation supports the use of Nothobranchius as a model to study age- and aggregate- 
related pathologies.  
Analyzing more closely the signs of Parkinson’s disease in Nothobranchius (i.e. neurodegeneration 
of locus coeruleus and posterior tuberculum together with pS129 immunoreactivity), I was able to 
detect a sort of pre-pathological state in N. furzeri brain, comprised of neurodegeneration and 
particular presence of pS129 immunoreactivity limited to Locus coeruleus cell bodies while no sign 
of such was detectable in the posterior tuberculum nucleus (teleost homologs to the mammalian 
Substantia nigra). Moreover, as evidenced by the vacuolar localization of aggresome staining, 
even if pS129 immunoreactivity was high already from a young age and worsening with age, I was 
not able to identify big aggregates corresponding to Lewy bodies. All this leads to the idea that N. 
furzeri could represent a good model of the initial, pre-pathological stages of PD. 
Regarding TDP-43 related pathology, I was able to identify a difference in TDP-43 localization in 
old animals with the appearance of a ‘doughnut-like’ staining near the nuclear border in line with 
the hypothesis of an alteration of nuclear-cytoplasmic transport and of TDP-43 function in FTD. I 
was also able to observe presence of TTDP-43 in Stress Granules, indicating that the role of this 
protein in SG formation and regulation is conserved in N. furzeri. 
 
It is my personal opinion that such findings could provide a turning point on the use of a powerful 
ageing model like Nothobranchius furzeri to uncover hidden mechanisms involved in aggregation-
related pathologies and strictly tied to ageing that have not yet been identified by the studies 
conducted in mammals. Taken together, my observations lead to the conclusion that 
Nothobranchius can be used as a powerful “tool” to study aspects of neurodegenerative diseases  
with approaches never used before, exploiting the natural short lifespan of this animal and its 
tendency to show signs of aggregation and pre-pathological states. This, coupled with the 
development of ex-vivo setups like organotypic culturing in this model could open exciting new 
avenues for ageing-related pathologiesresearch.  
For example, the use of organotypic cultures for observing ageing mechanisms ex-vivo and the 
possibility to perform drug testing to reduce ageing phenotypes could be of extreme importance 
for the field. For the study of neurodegenerative diseases and aggregation-related pathology there 
is still the need to confirm that the phenomena that I observed in vivo (e.g., pSyn accumulation 
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and neurodegeneration of LC, TDP-43 anormal distribution) occur also in long-term cultured slices. 
If that was the case, it would allow for specific study of the mechanism leading to such events and 
open the possibility of easy drug testing to try to prevent them, in a more physiological context 
respect to what is currently done in transgenic mice for instance. 
Overall, the data I obtained with my work could lead to a whole new area of research in 
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